TABLE OF CONTENTS Page Page Welcome to the 9th ESSM Congress ................2 Opening Ceremony ..........................................17 ESSM History ......................................................4 Program Schedule ............................................18 ESSM Committees ..............................................5 Scientific Program Sunday, 3 December 2006 ................................23 Monday, 4 December 2006 ..............................25 Tuesday, 5 December 2006 ..............................31 Wednesday, 6 December 2006..........................37 ESSM Award Winners ........................................6 Acknowledgements ..........................................6 Hofburg Congress Center Floor Plan ................7 General Information Congress Registration Counter ............................8 Registration Fees ................................................8 Congress Language ............................................9 Congress Documentation ....................................9 Congress Information System CO CONGRESS ONLINE® ..................................9 Speakers Service Centre and Lounge ..................9 ESSM Membership Issues ....................................9 Name Badges ......................................................9 Technical Exhibition ............................................9 Poster Exhibition................................................10 Poster CD ROM ................................................10 Internet Centre..................................................10 Press..................................................................10 Messages ..........................................................10 Restaurants ......................................................10 Coffee Breaks ................................................10 Cloakroom ........................................................10 Bank ................................................................11 Currency ..........................................................11 Electricity ..........................................................11 Lost and Found ................................................11 Mobile Phones ..................................................11 Program Changes..............................................11 Insurance ........................................................11 Airport ..............................................................11 Car Park ..........................................................11 Taxis ..................................................................11 Public Transportation Pass ................................12 How to get to the Hofburg Congress Center ....12 Supporting Program ........................................13 Introduction to the Scientific Program Format Descriptions ..........................................14 CME Credits......................................................15 ESSM Grants and Awards..................................16 Poster Presentations ........................................38 List of Exhibitors and Map ..............................54 List of Chairpersons and Presenters ..............55 Congress and Exhibition Office CPO HANSER SERVICE Hanser & Co GmbH P.O. Box 1221, 22882 Barsbüttel, Germany Telephone: +49-40-670 88 20 Telefax: +49-40-670 32 83 E-Mail: essm@cpo-hanser.de ESSM Secretariat Lavinia Ricci c/o AISC & MRG srl AIM Group Via Ripamonti 129, 20141 Milan, Italy Telephone: +39-025-6601 289 Telefax: +39-027-0048 577 E-Mail: admin@essm.org Scientific Secretariat Petter Hedlund Department of Clinical Pharmacology Lund University Hospital, 22 185 Lund, Sweden Telephone: +46-46-173 35 1 Telefax: +46-46-211 19 87 E-Mail: petter.hedlund@med.lu.se Congress Venue Hofburg Congress Center Heldenplatz, 1014 Vienna, Austria 1 2 WELCOME TO THE 9TH ESSM CONGRESS Dear Colleagues, I cordially welcome you to the 9th Congress of the European Society for Sexual Medicine in Vienna, to be held from December 3 – 6, 2006. The ESSM Congress is the most important event of our association and I am sure that it will be a great success for several reasons. S. Meryn The first reason is the programme. The programme organised by the ESSM Scientific Committee is very attractive for all practicing physicians with many debates and lectures on the different fields of sexual medicine. You will also be updated about all new technologies and treatments which will assist you in your daily practice. The second reason is the scientific one. The congress provides an excellent forum for active participation of basic research and clinical scientists. All scientists, and especially younger and more junior scientists, have been invited to submit abstracts for oral and poster presentations. The congress schedule provides ample opportunities for informal personal exchanges of ideas, data and findings, which we hope will stimulate international collaborations. The third reason is that Vienna is one of the most beautiful cities in the world, with a breathtaking range of social and entertainment opportunities, and is one of the centres of European culture in the heart of Europe. We also invite your partners to Vienna not to miss the opportunity to share with us a spectacular social programme for the accompanying people which will be particularly prepared for them. In addition, 2006 we celebrate the 250th anniversary of the birth of Wolfgang Amadeus Mozart, the most famous Austrian of all time. Austria is honouring this musical genius with a rich and varied calendar of extraordinary concerts, festivals, galas, expos and special exhibitions in Vienna. I look forward to welcoming you to the 9th ESSM Congress in Vienna. Prof. Siegfried Meryn, MD Chairman 9th ESSM Congress WELCOME TO THE 9TH ESSM CONGRESS Dear ESSM Members, Dear Friends, On behalf of the Executive and Scientific Committee of ESSM, I would like to welcome you to the 9th annual meeting of our Society in the beautiful city of Vienna. The scientific programme is outstanding and I am sure that you will all enjoy attending the various sessions covering the hottest topics in the field of Sexual Medicine. I am particularly grateful to the Chairman and Members of the Scientific Committee of ESSM who have devoted a significant amount of energy in organizing the best possible programme for you. F. Montorsi We received the highest number of abstracts in the history of ESSM and we did our best to select those who would capture your interest and would stimulate a lively discussion. During the meeting in Vienna, you will have the opportunity to attend the scientific sessions organized in collaboration with a number of sister Scientific Societies. This will give our meeting the widest international scientific breath. Our Society has been growing fast and I am proud to inform you that we currently have 19 National Societies of Sexual Medicine officially affiliated to ESSM. The future success of ESSM is certainly based on the capacity to spread our scientific knowledge as much as possible throughout whole Europe, in the ultimate interest of the best possible patients' care. I would finally like to thank Prof. Siegfried Meryn and all members of the Organizing Committee for the hard work done in organizing an elegant meeting, allowing us to taste the Vienna atmosphere which culminates at Christmas time. Welcome to Vienna and enjoy the Meeting. Warmest regards Prof. Francesco Montorsi, MD President, ESSM 3 4 ESSM HISTORY President ESSM Congress Venues and Chairmen Prof. Francesco Montorsi Department of Urology Universita' Vita Salute San Raffaele Via Olgettina 60 20132 Milan, Italy Telephone: +39-02-2643 7286 Telefax: +39-02-2643 7298 E-Mail: montorsi.francesco@hsr.it 1995 Porto Carras, Greece Dimitrios Hatzichristou, Greece 1997 Madrid, Spain Inigo Saenz de Tejada, Spain 2000 Barcelona, Spain Halim Hattat, Turkey 2001 Rome, Italy Francesco Montorsi, Italy 2002 Hamburg, Germany Hartmut Porst, Germany 2003 Istanbul, Turkey Emre Akkus, Turkey 2004 London, UK David Ralph, UK 2005 Copenhagen, Denmark Petter Hedlund, Sweden 2006 Vienna, Austria Siegfried Meryn, Austria 2007 Lisbon, Portugal Nuno Monteiro Pereira, Portugal 2008 Brussels, Belgium Joint Congress of ISSM/ESSM Eric Wespes, Belgium (ISSM) Claude Schulman, Belgium (ESSM) ESSM Secretariat Lavinia Ricci c/o AISC & MRG srl AIM Group Via Ripamonti 129 20141 Milan, Italy Telephone: +39-025-6601 289 Telefax: +39-027-0048 577 E-Mail: admin@essm.org Chairperson of the 9th ESSM Congress Prof. Siegfried Meryn President ASSM Medical University of Vienna Währinger Gürtel 18 - 20, P.O.Box 10 1097 Vienna, Austria Telephone: +43-1-409 60 10 Telefax: +43-1-409 60 11 E-Mail: s.meryn@assm.at ESSM Presidents 1993-1997 1997-1999 1999-2001 2001-2004 2004-2007 Gorm Wagner, Denmark Inigo Saenz de Tejada, Spain John Pryor, UK Dimitrios Hatzichristou, Greece Francesco Montorsi, Italy ESSM COMMITTEES Executive Committee President: Francesco Montorsi, Italy President Elect: Ian Eardley, UK Secretary General: Treasurer: Members: John Dean, UK Ian Eardley, UK Carlo Bettocchi, Italy Juza Chen, Israel Beatrice Cuzin, France Kerstin S. Fugl-Meyer, Sweden Annamaria Giraldi, Denmark Ates Kadioglu, Turkey Siegfried Meryn, Austria Ethical Chair: Members: Female Sexual Health Chair: Annamaria Giraldi, Denmark Members: Ellen Laan, The Netherlands Roy Levin, UK Ilan Gruenwald, Israel David Goldmeier, UK Primary Care Chair: Members: Scientific Committee Vienna 2006 Chair: Members: Petter Hedlund, Sweden John Dean, UK Annamaria Giraldi, Denmark Francois Giuliano, France Geoffrey Hackett, UK Siegfried Meryn, Austria Antonio Martin-Morales, Spain Ignacio Moncada, Spain Francesco Montorsi, Italy Marcel D. Waldinger, The Netherlands Kevan Wylie, UK Clinical Chair: Members: Francois Giuliano, France Javier Angulo, Spain Mario Maggi, Italy Stephan Ückert, Germany Antonio Martin-Morales, Spain Alberto Briganti, Italy Ian Eardley, UK Dirk Schultheiss, Germany Geoffrey Hackett, UK Bert-Jan de Boer, The Netherlands David Edwards, UK Doug Savage, UK Psychosexual Chair: Kevan Wylie, UK Members: Loukas Athanasiadis, Greece Marie Chevret-Measson, France Emmanuele Jannini, Italy Chiara Simonelli, Italy Mehmet Sungur, Turkey Surgery Chair: Members: Sub Committees Basic Science Chair: Members: Marcel D. Waldinger, The Netherlands Ulf Simonsen, Denmark Ignacio Moncada, Spain Fulvio Colombo, Italy Ates Kadioglu, Turkey Sava Perovic, Serbia and Montenegro David Ralph, UK National Organization Committee Chair: Members: Siegfried Meryn, Austria Elia Bragagna, Austria Bob Djavan, Austria Andreas Jungwirth, Austria Michael Marberger, Austria Eugen Plas, Austria Marianne Springer-Kremser, Austria Walter Stackl, Austria Astrid Zeitelberger-Renz, Austria 5 6 ESSM AWARD WINNERS / ACKNOWLEDGEMENTS ESSM Award Winners ESSM Award Winners Best Presentation Awards Career Awards 1995 Christian Stief, Germany 2002 John Pryor, UK 1997 Paul F. Engelhardt, Germany Francois Giuliano, France Suks Minhas, UK 2003 Gorm Wagner, Denmark 2004 Giles Brindley, UK Ronald Virag, France 2005 Karl-Erik Andersson, Sweden 2000 Apostolos Apostolidis, Greece F. Mumtaz, UK 2002 Annamaria Giraldi, Denmark 2003 Stefan Ückert, Germany Ilan Gruenwald, Israel Mustafa Usta, Turkey Alberto Briganti, Italy 2004 2005 Byoung Ahn, Republic of Korea Javier Angulo, Spain Antonio Aversa, Italy Award of Excellence 2002 Petter Hedlund, Sweden 2003 Selim Cellek, UK 2004 Stefan Ückert, Germany 2005 Javier Angulo, Spain Ekkehard W. Hauck, Germany Giovanni Corona, Italy Elke Gizewski, Germany Halim Hattat, Turkey Attila Kun, Hungary Sava Perovic, Serbia and Montenegro Acknowledgements The organizers of the 9th Congress of the European Society for Sexual Medicine gratefully acknowledge the support of the following companies (as per November 2006) Major Sponsors Bayer HealthCare AG Lilly ICOS LLC Pfizer Inc. Sponsors American Medical Systems Europe B.V. Ardana Bioscience Ltd. Coloplast (former Mentor Porges) Ipsen Pharma Janssen-Cilag Pharmaceutica NV Nature Publishing Plethora Solutions/Timm Medical Technologies Procter & Gamble Pharmaceuticals Schering AG Solvay Pharmaceuticals GmbH Uroan 21 HOFBURG CONGRESS CENTER - FLOOR PLAN HOFBURG CONGRESS CENTER Ground Floor Botschafterstiege Schatzkammersaal Forum Feststiege (Stairs to 1st Floor) Gardehalle I and II Counter Cloakroom Poster Exhibition Prinz-Eugen-Saal Speakers Centre and Lounge First Floor Entrance Heldenplatz Exhibition Area Radetzky III Marie Theresien III Radetzky I Theathergang Radetzky II Press Office Botschafterstiege Internet Centre Künstlerzimmer Marmorsaal Zeremoniensaal Geheime Ratstube Marie Theresien II Antekammer Rittersaal Trabantenstube Hofburg Galerie Seitengalerie Festsaal Heldenplatz (Stairs to Ground Floor) Feststiege 7 8 GENERAL INFORMATION Congress Registration Counter Registration/Check-in and arrival at the congress All congress materials and documentation will be available at the congress registration counter located in the entrance foyer of the Hofburg Congress Center in Vienna. Opening hours Sunday, 3 December 2006 Monday, 4 December 2006 Tuesday, 5 December 2006 Wednesday, 6 December 2006 8.00 7.00 7.30 7.30 - 19.30 19.30 18.00 12.30 h h h h During these opening hours the congress counter can be reached at: Telephone: +43-1-536 44-223 +43-1-536 44-224 Telefax: +43-1-536 44-226 ESSM Members, Physicians (MD) EUR 500 Non-Members, Physicians (MD) EUR 600 ESSM Members with reduced fees* Nurses, Residents in Training, Scientists (PhD), Psychologists, Therapists, Students EUR 400 Non-Members with reduced fees* Nurses, Residents in Training, Scientists (PhD), Psychologists, Therapists, Students EUR 500 Retired Delegates EUR 80 Accompanying Persons EUR 85 * A letter of the Chairman of the Department is necessary. Registration fee for participants includes: The congress counter will be divided into the following sections: On-Site Registration On-site registration for the congress. Pre-Registration Participants who have already registered for the congress will receive their documents here. Hotel Reservations Assistance for the reservation of hotel rooms in Vienna will be provided here. Information The staff of the information counter will be pleased to provide you with information about the congress, the congress centre, the hotels and the city of Vienna. They will also assist with restaurant information. Press Accreditation Press who has already pre-registered or will register on-site. For press accreditation an official press identity card is required. Admission to all scientific sessions Admission to the poster and technical exhibition Admission to the ESSM Gala Opening Ceremony and Welcome Reception on 3 December 2006 Conference materials (delegate bag, final program, abstract book, etc.) Coffee breaks and lunches from Monday, 4 December 2006 until Wednesday, 6 December 2006 ending with a coffee break in the morning. Use of the Vienna public transportation system from Sunday, 3 December 2006 to Wednesday, 6 December 2006 Registration fee for accompanying persons includes: Admission to the ESSM Gala Opening Ceremony and Welcome Reception on 3 December 2006 Half Day City Sightseeing Tour of Vienna (pre-registration necessary) Use of the Vienna public transportation system from Sunday, 3 December 2006 to Wednesday, 6 December 2006 GENERAL INFORMATION Congress Language The congress language is English. Simultaneous translation will not be provided. Congress Documentation The ESSM will offer its members to view parts of the scientific schedule online through a web-based system from the new ESSM homepage. Therefore several lectures will be filmed during the congress. will be available afterwards on a special congress notebook in the hall of the presentation. Due to time and technical reasons we kindly ask the speakers not to use their own notebook. Several PC working stations are provided in the speakers centre where speakers can also work on their PC charts in a quiet area. Technical staff will be glad to assist. A speakers lounge is provided in a separate area of room Erzherzog Karl Saal. Please see as well page 7. ESSM Membership Issues Congress Information System www.essm2006.org Participants can benefit from the web based ESSM Congress Information System CO CONGRESS ONLINE® on-site in the exhibition hall at the Internet centre. They can set up and print out a personal congress program schedule. The ESSM Congress Information System provides information on: Updated scientific program Program by day Program by formats with accepted abstracts of chairpersons and speakers Program search List of participants (who is who) For ESSM membership issues and any other ESSM business, please contact our ESSM booth which is situated in the exhibition area, at the Trabantenstube. Name Badges All participants are strongly requested to wear their name badge at all times during the congress. The colours of the name badge have the following significance: Delegate: Accompanying person: Press: Exhibitor: Staff: Blue Orange Yellow Green Red List of exhibitors and sponsors General congress information Private mailbox Speakers Centre and Lounge The speakers centre and lounge is located in the Erzherzog Karl Saal on the ground floor. Speakers are asked to hand in their CD ROM or USB stick, containing the PowerPoint presentation (IBM format or compatible, no multisession) preferably one day before their presentation but at the latest 90 minutes prior to the presentation. The presentation will be transferred to the central congress server and Technical Exhibition A major technical exhibition will take place on the first floor of the Hofburg Congress Center next to the main meeting rooms. Coffee bars and catering stations will be set up at various areas in the technical exhibition. For further information, please see page 55. (List of exhibitors) Opening hours Monday, 4 December 2006 09.00 – 17.00 h Tuesday, 5 December 2006 09.00 – 17.00 h Wednesday, 6 December 2006 09.00 – 12.30 h 9 10 GENERAL INFORMATION Poster Exhibition Press The moderated posters will be located in and in front of the Forum. All moderated poster sessions will take place in the Forum. The moderated posters in the room will be changed daily according to the sessions. The press centre is set up in the Maria Theresien Appartments on the first floor of the Hofburg Congress Centre. It is open from Monday, 4 December through Wednesday, 6 December 2006. The press centre is managed by the press agency FCB Events & PR. The unmoderated posters will be sited in the Gardehalle I and II next to the main meeting rooms Forum and Prinz Eugen Saal and the registration counter on the ground floor of the Hofburg. All moderated and unmoderated posters will be displayed during the whole conference. They will be arranged according to topics and will be numbered within the topics. The poster exhibition is open to all participants: Monday 4 December 2006 09.00 – 17.30 h Tuesday 5 December 2006 09.00 – 17.30 h Wednesday 6 December 2006 09.00 – 12.30 h Interested participants can meet the authors for discussion of their posters during following times: Monday, 4 December 2006 Tuesday, 5 December 2006 15.00 - 15.30 h 15.00 - 15.30 h Poster CD ROM A CD ROM including all poster presentations will be produced and all delegates will receive the poster CD ROM by post after the congress. All poster authors who have not yet submitted their poster are kindly asked to do so electronically either on CD ROM or on USB stick at the speakers centre. Internet Centre Several Internet terminals are available to all delegates at the exhibition area at the Entreezimmer of the Hofburg Congress Center. The Internet centre is accessible according to the opening hours of the exhibition. Messages A message board will be available at the registration area of the congress. Restaurants During the congress on Monday and Tuesday a complimentary snack buffet will be offered during lunch time for all registered congress delegates. Various restaurants and typical Viennese Cafés can be found in walking distance of the congress venue. Coffee Breaks Coffee and tea are served during the morning and afternoon coffee breaks from Monday, 4 December to Wednesday, 6 December 2006 free of charge to all participants wearing congress name badges. Various coffee stations are located in the exhibition area of the Hofburg Congress Center. Cloakroom A cloakroom is available next to the registration counter on the ground floor. You can also store your luggage here. GENERAL INFORMATION Bank Insurance An ATM/cash machine is located outside the Hofburg Congress Center at the Michaelerplatz within two minutes walking distance. The congress fee does not include insurance. All participants are advised to arrange for their own insurance. Health and accident insurance is recommended and has to be purchased in your country of residence. The organisers will not be responsible for a loss or damage of personal belongings. Currency The Euro is the official currency in Austria. Exchange of foreign currency is available at the Vienna Airport and at most hotels, banks and exchange offices throughout the city. Electricity Austria uses a 230 volt 50Hz system. Sockets have the European standard and plugs are two-prong grounded. Airport Vienna International Airport – Schwechat is in 15 km distance to the city centre. The express direct train CAT departs every 30 minutes from the International Airport to the Vienna city centre and takes 16 minutes. A one way ticket costs EUR 9. Within Vienna the Hofburg is easy accessible by public transportation. The taxi fare from the airport to any of the congress hotels and congress venue is expected to be approximately EUR 50. Lost and Found A lost and found service is available at the Hofburg Congress Center Information located in the entrance foyer of the congress venue. Car Park Parking space is available next to the Hofburg Congress Center and participants arriving by car are advised to use these facilities. Parking fees are not included in the registration fee. Mobile Phones Participants are kindly requested to keep their mobile phones turned off while attending the scientific sessions in the meeting rooms. Program Changes The organisers cannot assume liability for any changes in the congress program due to external or unforeseen circumstances. Taxis Taxis are available upon demand in front of the entrance of the Hofburg Congress Center. Participants can also call taxis at the Hofburg Congress Center information counter in the entrance foyer. 11 GENERAL INFORMATION Public Transportation Pass How to get to the Hofburg Congress Center Registered participants receive a public transportation pass in exchange for a voucher which is included in the participants’ congress materials. The congress materials can be picked up at the congress counter upon arrival. The public transportation pass is valid for all public transportation during the congress period, i.e. from Sunday, 3 December 2006 through Wednesday, 6 December 2006. Vienna’s public transportation system includes subways, trams and buses. Most of the hotels available are located in the city centre and are easy to be reached by public transportation from the congress venue. tte nr i Bus 2A, 3A (exit Michaelerplatz) ho Schottentor ho Tram D, J, 1, 2 (exit Burgring) i Sc Sc Underground / U-Bahn U1 (exit Stephansplatz) or U3 (exit Herrengasse) Ka U2 tte ng as se 2A ,3 A Tu 2A ch , 3 la A ub e Schwedenplatz ey un g Ring Dr. K. Renner 2A ,3 A Herrengasse MICHAELERPLATZ hauflerg. Sc U1 STEPHANSPLATZ U3 H City Airport Terminal O Stephansplatz FB U Strafle fs t g rin en ub tr. eth ers by car rs tr. in OPER g D, J K , D, J 1 ,2 U2 3A er R in g Parkgarage Oper U1 Sc M useumsquartier Parkgarage Le M eridien le ei kr in You reach the Hofburg Youcan can reach us via via public transportation: public transportation: Underground: U1, U3 Underground: Tramway: D, J, 1, 2 U1, U3 Tramway: 2A, 3A D, J,1,2 Bus: Bus: U4 rg RICHTUNG A2 S‹ DAUTOBAHN nbe Congress Entrance at Heldenplatz Par rze nz Stadtpark ing wa Li ie W ertr KARLSPLATZ U2 e nk hub Karlsplatz U4 Sch 2A RICHTUNG A1 WESTAUTOBAHN 1 ge 2 tz er g la nb r sp B e ab rn m pe eu O us St g RICHTUNG FLUGHAFEN of rin M Parkgarage useumsquartier Tramway Underground Bus U4 Landstrasse U3 Te g J, 2A MARIA THERESIEN PLATZ g. r. tin 3AAugus rg1 BJu, 2 D, D, Volkstheater en K r tn er RG CAT P3laA nk JOSEFSPLATZ HELDENPLATZ U3 U1 U3 L Parkgarage Rathaus U4 n Fr L welstra Dr. K. Leuger Ring A ,3 2A AM HOF D, J, 1 D, J, 2 RATHAUSPLATZ e ss 12 2A, 3A Josefsplatz no parking-site! Only for delivery Josefsplatz no parking-site! (freight vehicles below 7,5t) Only for delivery (freight vehicles below 7,5t) SUPPORTING PROGRAM Official ESSM Vienna Sightseeing Tour Monday, 4 December 2006 14.00 - 17.30 h This tour includes the main sights and highlights of Vienna. It starts with a drive along the famous Ringstrasse with its magnificant buildings, such as the Vienna State Opera, the Imperial Palace, the Museum of Fine Arts and the Museum of Natural History. “Following Sisi’s Footsteps...” Tuesday - Saturday 9.45 - 13.15 h Discover some of the delightful features of Vienna on a stroll through the center of Vienna. We start our walk with a visit to the Imperial Crypt, the burial of the Habsburgs, where Empress Elisabeth "Sisi" is also buried. Before a visit to the Hofburg Palace, the former official residence of Sisi and Franz Josef, you have the possibility to watch the training of the world famous Lipizzaner horses. Here the tradion of the High School of Riding is still cherished. The tour ends at the Hofburg. Entrance fee for the Spanish Riding School has to be paid seperately. Price per person: EUR 37 For information and booking, please contact: Mrs Michaela Ulreich michaela.ulreich@viennasightseeingtours.com Phone: 0043-1-712 46 83 80 www.viennasightseeing.at The tour continues to Schönbrunn Palace. The former summer residence of the Habsburg family with its more than 1400 state rooms and the extensive park is a splendid example of Baroque culture. A 45-minutes highlight tour takes you to 22 splendid rooms, such as the Grand Gallery and the Chinese Cabinets. After the tour there will be some free time to explore one of the nicest Christmas Markets in Vienna, called Ehrenhof right in front of the palace, this includes a 16 m high illuminated Christmas tree. The Christmas market invites to stroll around the market, taste some hot wine and Austrian Christmas cookies or buy some Christmas gifts there. On the way back the tour passes by the Belvedere Palace, the former summer residence of Prince Eugen, which houses the largest Gustav Klimt collection in the world. This tour will start and end at the Vienna Hofburg. Places are limited and will be assigned on a firstcome, first-served basis. Price per person: EUR 45 For registered accompanying persons this tour is complimentary. Meeting point is the main entrance of the congress at the Heldenplatz. Strauss and Mozart Concert at the Kursalon Daily 20.00 h The “Salonorchester Alt Wien”, one of the best known performers of Viennese classical music, ignites explosive fireworks with the most beautiful of compositions by "Waltz King" Johann Strauss and his contemporaries. Virtuosic musicians, extraordinary opera singers, and enchanting ballet dancers present an evening filled with Viennese charm and joyful waltzes, polkas, and operetta melodies of the highest artistic calibre. For information and booking, please contact: sound@soundofvienna.at Phone: 0043-1-512 57 90 www.soundofvienna.at Reference for special rates: ESSM 2006 13 14 INTRODUCTION TO THE SCIENTIFIC PROGRAM Structure of the Scientific Program The scientific program is structured according to days. Per day it is structured by time and room. All presenters are listed by name and the title of their presentation. Structure of the Abstract Book The abstract book is structured by session format. The listing starts with the podium session followed by the moderated poster sessions. Hereafter the unmoderated posters are listed according to topics. FORMAT DESCRIPTIONS Master Lecture Debates Each lecture of 30 minutes will be given by a distinguished and renowned expert and will be devoted to a specific topic of major interest. Debates last for 60 minutes and are designed to cover controversial issues of a particular topic. The moderator will allow a short introduction for each topic by the respective opponents followed by a discussion on the arguments proposed. Comments, arguments, and questions from the floor are welcomed during the discussion. Round Table These sessions will usually last 90 minutes. They will focus on a particular topic and present the very latest data related to it. The round table will include a maximum of four papers and time for discussion. Best Papers A selection of the year’s original scientific publications of particular importance for a specific topic within sexual medicine will be highlighted by the chairpersons during 90 minutes. Each paper will be briefly summarized and discoveries or other information of special interest will be given attention in relation to current knowledge and future perspectives. Interactive Sessions These sessions will last 90 minutes and present case discussions with a questioner and a panel of experts. Attendees will be given the possibility to interact actively via a voting system with the faculty of the session. Point-Counterpoint Sessions These sessions are organized to address one controversial issue of a topic. The moderator will allow a brief introduction for each topic by the respective opponents followed by a discussion on the arguments proposed. Instructional Courses These 90 minutes sessions present a detailed account of a chosen topic. Courses are designed to provide learning experiences that actively involve participants and will include an opportunity for informal exchange with the faculty. INTRODUCTION TO THE SCIENTIFIC PROGRAM Podium Sessions Symposia organized by the Industry Podium Sessions will present the best abstract papers accepted for the congress by the Scientific Committee and will focus on specific topics presenting the very latest findings in this field. Each session will last 90 minutes and will consist of max. 10 presentations per session. Each presentation is limited to 7 minutes followed by 2 minutes of discussion. Symposia organised by the Industry in consultation with the Scientific Committee will be presented at the afternoon on Sunday, 3 December 2006 before the Gala Opening and on Monday, 4 December 2006 and Tuesday, 5 December 2006 during lunchtime and in the late afternoon. CME (Continuing Medical Education) Moderated Poster Sessions Authors were invited to submit papers on their latest research findings or important ongoing research. The moderated poster sessions were selected by the Scientific Committee based on a review of all abstract submissions. The most interesting posters are grouped by topic and presented in a 90-minute moderated session. Each session will consist of a maximum of 15 talks in the same general field. Each presentation is limited to 4 minutes followed by 2 minutes of discussion. Posters Authors were invited to submit papers on their latest research findings or important ongoing research. Posters were selected by the Scientific Committee based on the review of all abstract submissions. The most interesting posters are grouped into one of 16 general areas of research. The poster exhibition is scheduled from Monday, 4 December, 2006 to Wednesday, 6 December 2006 and will take place at the Gardehalle I and II on the ground floor of the Hofburg. Video Surgery Course The Video Surgery Course on Sunday, 3 December 2006, will last 120 minutes, each video has a duration of 10 to 15 minutes. A panel of selected experts will present surgical videos showing different techniques and approaches and will discuss the details with the participants. This congress has been submitted for UEMS accreditation to the European Accreditation Council for Continuing Medical Education (EACCME). Physicians will be accredited with CME credits for the whole period of the congress. EACCME credits are recognised by the American Medical Association towards Physician's Recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, please contact the AMA. The accreditation form for international physicians is available on the AMA website at www.ama-assn.org. Choose the button ContMedEduc (CME) and follow the link AMA PRA. This congress has been submitted for CME accreditation to the Italian Ministry of Health. Physicians will be accredited. You will find the CME evaluation forms in your personal documents. Italian delegates are asked to fill them in and leave them at the ESSM booth in the exhibition area at the end of the congress. The ESSM Secretariat will send the certificate after the congress. 15 16 GRANTS AND AWARDS Meeting Awards The best presentations will be awarded with EUR 2.000 by ESSM’s Award Committees. 1. Prize for the best presentation on FSD (preclinical) 2. Prize for the best presentation on FSD (clinical) 3. Prize for the best presentation on MSD (preclinical) 4. Prize for the best presentation on MSD (clinical) 5. Prize for the best surgical presentation The ESSM Prestige Awards The Executive Committee of ESSM decided to establish two awards to be presented during the annual meetings of the society: The ESSM Career Award This award will be presented to a senior scientist who has made an outstanding contribution in the field. The Executive Committee has decided for an award winner. The award winner will be presented during the Opening Ceremony. The ESSM Award of Excellence This award is presented annually to a young scientist who has accomplished exceptional achievement in the field. Eligible applicants are physicians and scientists under the age of 40 with significant contribution to the field. EASM Fellowship Program and Introductory Course The European Academy of Sexual Medicine (EASM) is a not-for-profit educational organisation with its objective “to establish, harmonise and maintain standards for the education and practice of sexual medicine throughout Europe”. It was established as a wholly independent body and with the full support of the European Society for Sexual Medicine and the European Federation of Sexology. One of its principal aims is to establish a respected and academically rigorous qualification in sexual medicine for medical practitioners, the Fellowship of the EASM. The Fellowship Program is open to candidates who are registered medical practitioners, holding a specialist qualification in an appropriate speciality, including family medicine/general practice. The fellowship will be awarded to those who, following a prescribed period of professional training and practical experience, and attendance at approved structured courses, pass the required examination and assessments. It is anticipated that the first intake of candidates to the Fellowship Programme will take place in December 2006 and that the first introductory course will be held during the ESSM 2006 Congress in Vienna. It is hoped that the program will eventually be available in all European countries, and be delivered in all European languages. Initially, it will be available in English and possibly in a limited number of other languages according to demand and availability of learning/teaching opportunities. OPENING CEREMONY GALA OPENING CEREMONY followed by the ESSM WELCOME RECEPTION Festsaal at the Hofburg, Sunday, 3 December 2006 18.15 – 20.30 h Don’t miss the outstanding MOZART GALA Throughout the world, Vienna has a reputation as the capital of music. The ESSM opening ceremony 2006 will be a celebration in honours of the unrivalled musical genius WOLFGANG AMADEUS MOZART, whose 250th birthday falls in 2006. This extraordinary evening event dedicated to the probably most famous Austrian will be the social highlight of the 9th ESSM Congress besides the outstanding scientific program. The welcome speeches from Prof. Montorsi, president of the ESSM and Prof. Meryn, local president of the 9th congress of the European Society for Sexual Medicine will be accompanied by unique interpretations by members of the World famous Vienna Philharmonic Orchestra and the Vienna State Opera Ballett will be presented in the Festsaal at the Hofburg. The music ensemble “Mozart Sinfonietta Wien” was founded in 1988 in Vienna, one of the most important cities in the life of Wolfgang Amadeus. This Viennese orchestra is dedicated not only to the performance of music by W. A. Mozart. Important part of its work is to find and perform new definitions of the semantic contents in Mozart’s music. Members of the “Mozart Sinfonietta Wien” are excellent musicians from the world famous Viennese Symphonic Orchestras, mainly from the Vienna Philharmonic. All these brilliant musicians bring their large experience and knowledge in to the work of the orchestra. At the same time traditional and evolutional, the “Mozart Sinfonietta Wien” brings the genius of Mozart’s music close to its audience. September 2005 marked a new departure for the Ballet of the Vienna State Opera and Volksoper, when merging the previously completely separate ensembles of the two opera houses. This new policy will enable the restructured ensemble to preserve the centuries-old tradition of the Vienna ballet as one of the oldest and most legendary institutions in the filed of this genre. The vienna waltz project was founded by soloist and dancers of the world famous Ballet of the Vienna State Opera. To bring the fascination of creative dance performances to people all over the world is the goal for the innovative work of these artists. Starting from classical ballet on highest level all sectors, stiles and forms of the art of dancing are developed. Modern dance, Vienna waltzes, Rap, Dance shows or solo-ballet, Kuala Lumpur or Wolfgang-See – the vienna waltz project covers a big variation of performance styles and places. In Canada, the US, Moscow, Mallorca – everywhere these dancers conquer their audience with innovative dance. A multicoloured collage of dance and music, as animated and multifaceted as the life of Mozart himself will ensure an unforgettable evening. At the end of the opening ceremony all participants are invited to join a specially arranged Welcome Reception. 17 18 PROGRAM SCHEDULE Sunday, 3 December 2006 Room Time Festsaal Zeremoniensaal Various Meeting Rooms 09.00 - Entrance Foyer 08.00 - 19.30 h Registration at the Entrance Area 09.30 10.00 10.30 11.00 11.30 - Meetings of Affiliated Societies 12.00 12.30 13.00 13.30 V-1 Video Surgery Course 14.00 14.30 15.00 - D-1 The JSM Debate 15.30 16.00 - S-1 16.30 - New Developments in Sexual Medicine, Schering AG 17.00 S-2 Clinical & Scientific Advances in PE, Janssen-Cilag 17.30 18.00 - Pharmaceutica NV 18.30 19.00 - Opening Ceremony 19.30 Welcome Reception in the Entrance Hall of the Vienna Hofburg 20.00 20.30 - Abbreviations ML Master Lecture CP Point Counterpoint Session R Round Table C B Best Papers HS History Session I Interactive Session P Podium Session D Debate S Satellite Symposium MP V Instructional Course Moderated Poster Session Video Course PROGRAM SCHEDULE Monday, 4 December 2006 Room Time Festsaal Zeremoniensaal Forum Prinz Eugen Saal 07.00 - 19.30 h Registration at the Entrance Area 08.00 - ML-1 ISSM Lecture 08.30 ML-2 ISSWSH Lecture 09.00 ML-3 HIV-related FSD 09.30 Coffee Break 10.00 10.30 11.00 11.30 12.00 - B-1 Erectile Dysfunction Best Papers 2006 P-1 Hormones and Sexuality MP-1 Female Sexual Health C-1 How implant a Penile Prosthesis CP-1 ML-4 Quality of life Hypogonadism and ED when treating ED Lunch Break 12.30 - S-3 Connecting the Dots in ED Treatment: 13.00 - Erectile Function and Satisfaction, Pfizer Inc. 13.30 14.00 14.30 - I-1 B-2 Female Sexual Health Surgery/Peyronie’s Best Papers 2006 P-2 Pathophysiology of Sexual Dysfunctions C-2 Testosterone Replacement 15.00 Coffee Break 15.30 R-1 The Ageing Couple 16.00 - MP-2 Pharmacology 16.30 17.00 - S-4 Integrating Partners into ED Treatment: Unrealistic or 18.00 - Mandatory? 17.30 - Bayer HealthCare AG 18.30 19.00 - ESSM Business Meeting 19.30 20.00 - Entrance Foyer Individual Dinner Invitations C-3 Basics in Ejaculatory Disorders 09.00 - 17.00 h Exhibition in various areas of the Hofburg, first floor 19 20 PROGRAM SCHEDULE Tuesday, 5 December 2006 Room Time Festsaal Zeremoniensaal Forum Prinz Eugen Saal 07.30 - 18.00 h Registration at the Entrance Area 08.00 08.30 09.00 09.30 10.00 ML-5 ESAU Lecture ML-6 SMSNA Lecture ML-7 ESSM Award Lecture Coffee Break - 10.30 11.00 11.30 12.00 - S-5 Satellite Symposium Coffee Break Solvay Pharmaceuticals R-2 P-3 MP-3 More Hot Topics with Female Sexual Health Physiology and PDE5 Inhibitors Pathophysiology C-4 Psychotherapies in Premature Ejaculation CP-2 HS-1 PDE5 Inhibitors for PE ESSM History Session Lunch Break 12.30 - S-6 From Clinical Study to 13.00 - Clinical Practice Lilly ICOS LLC 13.30 14.00 - I-2 Ejaculatory Disorders P-4 Pharmacology MP-4 Surgery, Peyronie’s Disease and Priapism 14.30 - C-5 Basics in Erectile Dysfunction 15.00 Coffee Break 15.30 16.00 16.30 17.00 17.30 - B-3 Female Sexual Health Best Papers 2006 P-5 Ejaculatory Disorders C-6 Advanced ED Management - from Pharmacotherapy to Penile Implant S-7 Satellite Symposium Procter & Gamble Pharmaceuticals 18.00 18.30 19.00 - Individual Dinner Invitations 19.30 20.00 - Entrance Foyer 09.00 - 17.00 h Exhibition in various areas of the Hofburg, first floor PROGRAM SCHEDULE Wednesday, 6 December 2006 Room Time Festsaal Zeremoniensaal Forum Entrance Foyer C-7 Basics in Female Sexual Health 07.30 - 12.30 h Registration at the Entrance Area 08.00 I-3 08.30 Erectile Dysfunction 09.00 - P-6 Erectile Dysfunction following Radical Prostactectomy 09.30 Coffee Break 10.00 10.30 - ML-8 R-3 Drug Misuse and Sexuality The ESDA Experience B-4 Ejaculatory and Orgasmic Disorders 11.30 - Best Papers 2006 11.00 - 12.00 Closing Remarks 12.30 - P-7 Surgery and Peyronie’s Disease MP-5 General Issues in Sexual Medicine 09.00 - 12.30 h Exhibition in various areas of the Hofburg, first floor 21 QBPQLPQBOLKBRKAB@>KL>QB LK@BKQO>QFLKRKABO@LKQOLI B?FALܓ ‚FKGB@QFLKPMBOVB>ORPR>IIVJ>FKQ>FK PBORJQBPQLPQBOLKBIBSBIPFKQEBMEVPFLILDF@>I O>KDB’ €ˆˆ„’ˆ…„† B?FALÜ ªBPQLPQBOLKBRKAB@>KL>QB« OBP@OF?FKDKCLOJ>QFLK EBO>MBRQF@FKAF@>QFLKP BPQLPQBOLKB QEBO>MV FK @LKCFOJBA J>IB EVML¦ DLK>AFPJ’ LJMLPFQFLK ‚ JI PLIRQFLK @LKQ>FKFKD“ ˆˆˆ JD QBPQLPQBO¦ LKBRKAB@>KL>QB>P>@QFSBFKDOBAFBKQ>KA?BK¦ WVI?BKWL>QB>KA@>PQLOLFI>PBU@FMFBKQP LKQO>FKAF@>QFLKP >PBPLC HKLTKLOPRPMB@QBA>KAOLDBK¦ABMBK¦ ABKQ@>O@FKLJ>LC QEBMOLPQ>QBLOLC QEBJ>IB J>JJ>OVDI>KA�M>PQLOMOBPBKQIFSBOQRJLOP� EVMBOPBKPFQFSFQV QL QEB >@QFSB PR?PQ>K@BLO QL >KVLC QEBBU@FMFBKQP’’ FABBCCB@QP AJFKFPQO>QFLK PFQB“ M>FK >KA¥LO EBJ>QLJ>’ LPPF?IB PVPQBJF@ PFAB BCCB@QP“ AF>OOEB>— IBD M>FK— >OQEO>IDF>— AFWWFKBPP— FK@OB>PBAPTB>QFKD— EB>A>@EB— OBPMFO>QLOV AFPLOABO— >@KB— ?OB>PQ M>FK— DVKB@LJ>PQF>— MOROFQRP— PHFKAFPLOABO— QBP¦ QF@RI>OM>FK— MOLPQ>QBAFPLOABO’ QEBOHKLTK>A¦ SBOPB AORD OB>@QFLKP LC QOB>QJBKQP @LKQ>FK¦ FKD QBPQLPQBOLKB >OB“ O>OB @>PBP LC MLIV@VQEB¦ JF>— TBFDEQ D>FK— BIB@QOLIVQB @E>KDBP— JRP@IB @O>JMP— KBOSLRPKBPP— ELPQFIFQV— ABMOBPPFLK— PIBBM>MKB>— FKSBOVO>OB@>PBPG>RKAF@B>KAIFS¦ BO¦CRK@QFLK¦QBPQ>?KLOJ>IFQFBP— S>OFLRPPHFKOB¦ >@QFLKP FK@IRAFKD >@KB— PB?LOOEB>— >KA ?>IA¦ FKD— IF?FAL @E>KDBP— FK@OB>PBA COBNRBK@V LC BOB@QFLKP— MBOPFPQBKQ— M>FKCRI BOB@QFLKP ªMOF>¦ MFPJ«’ OB>QJBKQTFQEEFDEALPBPLC QBPQLPQBO¦ LKB MOBM>O>QFLKP @LJJLKIV OBSBOPF?IV FKQBO¦ ORMQP LO OBAR@BP PMBOJ>QLDBKBPFP— QEBOB?V OB¦ AR@FKD QEB PFWB LC QEB QBPQF@IBP� EFDE¦ALPBA LO ILKD¦QBOJ>AJFKFPQO>QFLKLC QBPQLPQBOLKBL@@>¦ PFLK>IIVFK@OB>PBPQEBL@@ROOBK@BPLC T>QBOOB¦ QBKQFLK >KA BABJ>— ROFK>OV L?PQOR@QFLK— MOLP¦ Q>QB @>K@BOª>IQELRDE A>Q> LK MOLPQ>QB @>K@BO OFPH FK >PPL@F>QFLK TFQE QBPQLPQBOLKB QEBO>MV >OBFK@LK@IRPFSB«’ K MOBMR?BOQ>I¥MR?BOQ>I ?LVP QBPQLPQBOLKB— ?B¦ PFABP J>P@RIFKFW>QFLK— @>K @>RPB >@@BIBO>Q¦ BA DOLTQE >KA ?LKB J>QRO>QFLK >KA MOBJ>¦ QROBBMFMEVPB>I@ILPROB— QEBOB?VOBAR@FKDCFK>I EBFDEQ’ EB>MMB>O>K@BLC @LJJLK>@KBE>PQL ?BBUMB@QBA’ OB@>RQFLKP B?FALJFDEQOBPRIQFK>MLPFQFSBCFKAFKDFKALM¦ FKDQBPQP’ IABOM>QFBKQPQOB>QBATFQE>KAOLDBKP J>V?B>Q>KFK@OB>PBAOFPHCLOQEBABSBILMJBKQ LC MOLPQ>QF@EVMBOMI>PF>’ >O@FKLJ>LC QEBMOLP¦ Q>QB E>P QL ?B BU@IRABA ?BCLOB PQ>OQFKD QOB>Q¦ JBKQ TFQE QBPQLPQBOLKB MOBM>O>QFLKP’ BDRI>O BU>JFK>QFLKP LC QEB MOLPQ>QB >OB OB@LJJBKA¦ BA’ BJLDIL?FK >KA E>BJ>QL@OFQ PELRIA ?B @EB@HBA MBOFLAF@>IIV FK M>QFBKQP LK ILKD¦QBOJ >KAOLDBKQOB>QJBKQQLABQB@Q@>PBPLC MLIV@V¦ QEBJF>’ KO>OB@>PBP— ?BKFDKIFSBOQRJLOP— >KA BSBKJLOBO>OBIV— J>IFDK>KQIFSBOQRJLOPE>SB ?BBK OBMLOQBA FK RPBOP LC QBPQLPQBOLKB @LJ¦ MLRKAP’ K FPLI>QBA @>PBP— QEBPB QRJLOP E>SB IBAQLIFCB¦QEOB>QBKFKDFKQO>¦>?ALJFK>IEBJLO¦ OE>DBP’ EBM>QF@ QRJLO PELRIA ?B @LKPFABOBA FKQEBAFCCBOBKQF>IAF>DKLPFPTEBKPBSBOBRMMBO >?ALJFK>I M>FK— IFSBO BKI>ODBJBKQ LO PFDKP LC FKQO>¦>?ALJFK>IEBJLOOE>DBL@@ROFKJBKRP¦ FKDB?FAL’ >QFBKQPMOBAFPMLPBAQLBABJ>— M>¦ QFBKQP TEL E>SB E>A BIBS>QBA ?ILLA MOBPPROB— AFPQRO?>K@B FK OBK>I CRK@QFLK— BMFIBMPV LO JF¦ DO>FKB PELRIA ?B @ILPBIV JLKFQLOBA’ EB MOLA¦ R@QJ>VBIBS>QB?ILLAMOBPPROB>KAFPKLQOB@¦ LJJBKABACLOM>QFBKQPTFQE@>OAF>@FKPRCCF@FBK¦ @V’ OBBUFPQFKDPIBBM>MKB>J>V?BMLQBKQF>QBA’ B?FALE>PQL?BRPBATFQE@>RQFLKFKM>QFBKQP TFQE EVMBO@>I@BJF> ARB QL ?LKB JBQ>PQ>PBP’ BORJ@>I@FRJ@LK@BKQO>QFLKPE>SBQL?BJLK¦ FQLOBA OBDRI>OIV FK QEBPB M>QFBKQP’ KAOLDBKP >OBKLQPRFQ>?IBCLOBKE>K@FKDJRP@RI>OABSBI¦ LMJBKQFKEB>IQEVFKAFSFAR>IPLOCLOFK@OB>PFKD MEVPF@>I>?FIFQV’ LPLILDV>KAJBQELALC >AJFKFPQO>QFLK B?FAL FP FKGB@QBA BSBOV ˆ QL ‚ TBBHP’ KGB@QFLKPFKQEBPBFKQBOS>IPIB>AQL>KAJ>FK¦ Q>FK QBPQLPQBOLKB IBSBIP FK QEB MEVPFLILDF@>I O>KDB>KAALKLQIB>AQL>@@RJRI>QFLK’ B?FAL FPPQOF@QIVCLOFKQO>JRP@RI>OFKGB@QFLK>KAJRPQ ?BFKGB@QBASBOVPILTIV’ MB@F>I@>OBJRPQ?BDFS¦ BKQL>SLFAFKQO>S>P@RI>OFKGB@QFLK’ EBCFOPQFK¦ GB@QFLKFKQBOS>IJ>V?BOBAR@BAQL>JFKFJRJ LC „TBBHP’ FQEQEFPIL>AFKDALPB— PQB>AV¦PQ>QB IBSBIPTFII?BOB>@EBANRF@HIV’ MB@F>IT>OKFKDP EBRPBLC QEBMOLAR@QFKMOBMR?BOQ>I@EFIAOBK FPKLQOB@LJJBKABA’ KRK>SLFA>?IB@>PBPQEB QOB>QJBKQ PELRIA ?B @LKAR@QBA RKABO QEB PR¦ MBOSFPFLK LC QEB AL@QLO PMB@F>IFWBA FK MBAF>QOF@ BKAL@OFKLILDV’ B?FAL FP KLQ FKAF@>QBA CLO RPB FKTLJBK>KAJRPQKLQ?BRPBAFKMOBDK>KQLO I>@Q>QFKDTLJBK’ IB>PBOBCBOQLQEBRJJ>OVLC OLAR@QE>O>@¦ QBOFPQF@PCLOJLOBABQ>FIBAFKCLOJ>QFLK’ LOCRO¦ QEBOABQ>FIP@LKQ>@QVLROIL@>I@EBOFKDLOD>KF¦ P>QFLK’ >QBLC MOBM>O>QFLKLC “ ˆ RIV€ˆˆ„’ >QBLC MOBM>O>QFLKLC >A“ …@QL?BO€ˆˆ„’ ASBOPBOB>@QFLKP@>K?BOBMLOQBAQL óA>Q>>K>DBJBKQµP@EBOFKD’AB @EBOFKD— ‚€BOIFK— BOJ>KV KAOLILDV SCIENTIFIC PROGRAM Sunday, 3 December 2006 V-1 Video Surgery Course 13.00 - 15.00 Zeremoniensaal Chairs: David Ralph, United Kingdom Ates Kadioglu, Turkey Edoardo Austoni, Italy V-01-01 Glans excision and skin grafting for penile cancer Suks Minhas, United Kingdom V-01-02 Gender reassignment surgery procedures Michael Sohn, Germany V-01-03 Augmentation Phalloplasty / Soft prosthesis and albugineal incision Fulvio Colombo, Italy V-01-04 3 piece inflatable penile implant procedures Ignacio Moncada, Spain V-01-05 Nesbit or grafting David Ralph, United Kingdom V-01-06 Grafting or Nesbit Ates Kadioglu, Turkey V-01-07 Cavernous nerve stimulator and radical prostatectomy Francesco Montorsi, Italy V-01-08 Management of the epispadias penis Sava Perovic, Serbia and Montenegro V-01-09 Enlargement of the penis using intexen: A personal technique Piero Letizia, Italy V-01-10 Original space maintainer device in penile lengthening: A new technique Piero Letizia, Italy D-1 Debate 15.00 - 16.00 Zeremoniensaal The JSM Debate - Chronic dosing of PDE5 inhibitors should become the norm as such treatment improves erectile, heart and endothelial health Chair: Irwin Goldstein, USA ProSpeaker: ConSpeaker: S-1 Graham Jackson, United Kingdom Francesco Montorsi, Italy (tbc) John Dean, United Kingdom Yoram Vardi, Israel Satellite Symposium 16.00 - 17.00 Festsaal Testosterone Therapy: New Developments in Sexual Medicine Chairs: Jacques Buvat, France Eugen Plas, Austria S-01-01 Symptoms and prevalence of lateonset hypogonadism and relevance for sexual medicine Eugen Plas, Austria S-01-02 Development of the metabolic syndrome in relation to male hypogonadism Armin Heufelder, Germany S-01-03 Is there a link between ED, hypogonadism and risk factors of the metabolic syndrome? Ian Eardley, United Kingdom S-01-04 Safety, efficacy and sexual benefits of long-acting, injectable testosterone undecanoate (Nebido (R)) in men with low testosterone levels Herrmann Behre, Germany S-01-05 Co-therapy testosterone-PDE 5 inhibitors in hypogonadal ED patients: Rationale and perspectives Jacques Buvat, France sponsored by an educational grant of Schering AG. 23 24 SCIENTIFIC PROGRAM Sunday, 3 December 2006 S-2 Satellite Symposium 17.15 - 18.15 Zeremoniensaal Clinical & Scientific Advances in PE: From Diagnosis to Drug Treatment Chair: Hartmut Porst, Germany S-02-01 Factors affecting the diagnosis and impact of PE Chris McMahon, Australia S-02-02 The mode of action and clinical efficacy of dapoxetine in PE Francois Giuliano, France S-02-03 The evaluation of withdrawal effect with dapoxetine in the treatment of PE and its affect on distress and interpersonal difficulty: Richard Casey, Canada S-02-04 The tolerability and long-term efficacy of dapoxetine in PE Antonio Martin-Morales, Spain Opening Ceremony 18.15 - 19.30 Festsaal followed by a Welcome Reception on the ground floor of the Hofburg from 19.30 to 20.30 h. sponsered by an educational grant of Janssen-Cilag Pharmaceutica NV Technical Exhibition A major technical exhibition welcomes you in the Exhibition Area on the first ground of the Vienna Hofburg. Opening hours Monday, 4 December 2006 Tuesday, 5 December 2006 Wednesdy, 6, December 2006 09.00 - 17.00 h 09.00 - 17.00 h 09.00 - 12.30 h Poster Exhibition The poster exhibition takes place in the Gardehalle I and II on the ground floor of the Vienna Hofburg. Opening hours Monday, 4 December 2006 Tuesday, 5 December 2006 Wednesdy, 6, December 2006 09.00 - 17.30 h 09.00 - 17.30 h 09.00 - 12.30 h SCIENTIFIC PROGRAM Monday, 4 December 2006 ML-1 P-1 Master Lecture 08.00 - 08.30 Festsaal The ISSM Lecture Chair: Ian Eardley, United Kingdom ML-01-01 ML-2 Is there a relation between hypogonadism and the metabolic syndrome? Ridwan Shabsigh, USA ML-3 P-01-001 Assessment of the relational factor in male patients consulting for sexual dysfunction: The concept of couple sexual dysfunction Giovanni Corona, Italy L. Petrone, E. Mannucci, A. Magini, F. Lotti, V. Ricca, V. Chiarini, G. Forti, M. Maggi P-01-002 The role of the sexologist in sexual medicine Elena Longhi, Italy A. Salonia, R. Colombo, G. Zanni, C. Lania, A. Briganti, P. Rigatti, F. Montorsi P-01-003 Factors that contribute to sexual satisfaction Antonio Fernandez Lozano, Spain I. Sotolongo Vergo, E. Ruiz Castañe P-01-004 Community pharmacists’s views on sexual dysfunction Stamtis Papacharitou, Greece E. Nakopoulou, E. Katsohi, D. Kouvelas, D. Hatzichristou P-01-005 Testosterone regulates rhoa/ rho-kinase signalling in two distinct animal models of chemical diabetes Linda Vignozzi, Italy A. Morelli, S. Filippi, R. Mancina, M. Luconi, S. Ambrosini, G. B. Vannelli, G. Forti, M. Maggi P-01-006 Estrogens regulate epididymal contractility through rhoa/rho-kinase signalling Sandra Filippi, Italy A. Morelli, L. Vignozzi, R. Mancina, G. Forti, M. Maggi P-01-007 Androtest: A structured interview for the screening of hypogonadism in patients with sexual dysfunction Giovanni Corona, Italy L. Petrone, E. Mannucci, A. D. Fisher, G. Balercia, V. Chiarini, G. Forti, M. Maggi Hyposexual desire disorder - Attitudes to diagnosis and treatment Anita Clayton, USA Master Lecture 09.00 - 09.30 Festsaal Affect, anthropology and pharmacotherapy Culprits in HIV-related FSD Chair: Ellids Kristensen, Denmark Speaker: David Goldmeier, United Kingdom B-1 Best Papers 10.00 - 11.30 Festsaal Erectile Dysfunction Chairs: Francesco Montorsi, Italy Dimitrios Hatzichristou, Greece Zeremoniensaal Hormones and Sexuality Chairs: Jacques Buvat, France Eginhard Waldkirch, Germany Festsaal The ISSWSH Lecture Chair: Yoram Vardi, Israel ML-02-01 10.00 - 11.30 Master Lecture 08.30 - 09.00 Podium Session 25 26 SCIENTIFIC PROGRAM Monday, 4 December 2006 P-01-008 Positive impact of a new educational program to optimize treatment with sildenafil Gerry Brock, Canada S. Carrier, R. Casey, J.-E. Tarride, P. D’Angelo, S. Elliott, H. Dugre, C. Rousseau, I. Defoy P-01-009 Safety and tolerability of Transdermal Testosterone Patch (TTP) in surgically menopausal women receiving oral or transdermal estrogen over 36 months of therapy L. Nachtigall, USA P. Casson, J. Lucas, C. Melson, V. Schofield P-01-010 MP-1 Comparison of men and women of the BDSM community in Portugal: An internet based study Patricia Pascoal, Portugal R. Rui Henriques, N. Monteiro Pereira Moderated Poster Session 10.00 - 11.30 Forum Female Sexual Health Chairs: Irwin Goldstein, USA Daniel Richardson, United Kingdom MP-01-069 In vivo neuronal activity in the hypothalamus varies with oestrus cycle in female rats: Baseline conditions and effects of dopamine receptor agonism Natalie Richards, United Kingdom K. Allers MP-01-070 Pharmacological differences of neuropeptides between rabbit vaginal smooth muscle and vaginal arteries in vitro Karen Aughton, United Kingdom K. Hamilton-Smith, C. Wayman, M. Jackson MP-01-071 Is sexual function different in obese women? Baris Altay, Turkey B. Turna, U. Aliyeva, O. Kaan, E. Muktharov, S. Cetinkalp, C. Yilmaz, B. Semerci MP-01-072 Effects of intra-nasally administered testosterone on sexual behavior in female capuchin monkeys (Cebus apella) Bianca Topic, Germany M. C. Tavares, C. Tomaz, J. P. Huston, C. Mattern MP-01-073 Effects of hypoactive sexual desire disorder treatment on relationships Dianne Felblinger, USA P. E. Koochaki, K. Wekselman MP-01-074 To evaluate female sexual function after colpoperineoplasty Min Her, Republic of Korea J. Kim, E. Kim, J. Lee, H. Cho MP-01-075 Prevalence of female sexual dysfunction in Germany Results of the crossover-study „The Cologne 20.000 community survey“ Joanna Beate Korda, Germany M. Braun, H. Christ, M. Hellmich, U. Engelmann MP-01-076 Rethinking desire: Prevalence and correlates of desire discordance in the Nurses Sexuality Study Michael Sand, Germany MP-01-077 Nocturnal Vaginal pH-Meter: Can it be a new screening method for female sexual dysfunction Levent Peskircioglu, Turkey M. R. Goren, A. Dirim, H. Ozkardes MP-01-078 Development and validation of a new screening tool for hypoactive sexual desire disorder: The Brief Profile of Female Sexual Function© (B-PFSF©) S. Golombok, United Kingdom L. Derogatis, C. Rodenberg, P. Koochaki, S. Schmitt, J. Rust SCIENTIFIC PROGRAM Monday, 4 December 2006 MP-01-079 Development and initial validation of the Female Assessment of Male Erectile Dysfunction Detection Scale (FAME): Report of a pilot study Eusebio Rubio-Aurioles, Mexico I. Arango de Montis, N. T. Roccatti, M. Sand MP-01-080 Presence of a sexual dysfunction may not always affect women’s satisfaction from their sexual function Fotini Ferenidou, Greece V. Kapoteli, K. Moysidis, I. Koutsogiannis, A. Giakoumelos, D. Hatzichristou MP-01-081 Effect of Topical Misoprostole on Clitoral Hemodynamics Levent Peskircioglu, Turkey M. R. Goren, S. R. Erdem, A. I. Oguzulgen, H. Ozkardes MP-01-082 Effects of the dopamine receptor agonist, apomorphine on unconditioned sexual incentive motivation in ovariectomised female rats Tony Hawcock, United Kingdom L. Turner, T. Dawkins, N. Edmunds MP-01-083 �Receptivity score’: An improved measure of sexual arousal in the rat Tony Hawcock, United Kingdom S. Katechia, N. Edmunds C-1 Instructional Course 10.00 - 11.30 Prinz-Eugen-Saal How implant a penile prosthesis Chair: Carlo Bettocchi, Italy C-01-01 Couple counselling and patient selection Amanda Spillings, United Kingdom C-01-02 Penile prosthesis - selecting prothesis and surgical tricks David Ralph, United Kingdom C-01-03 Result and long-time follow-up Mariano Rossello Barbara, Spain C-01-04 Penile prosthesis complications how to manage Carlo Bettocchi, Italy CP-1 Point Counterpoint Session 11.30 - 12.00 Festsaal Hypogonadism and Erectile Dysfunction - What to treat first? Chair: Christian Stief, Germany CP-01-01 Hypogonadism Mario Maggi, Italy CP-01-02 Erectile Dysfunction Inigo Saenz de Tejada, Spain ML-4 Master Lecture 11.30 - 12.00 Zeremoniensaal Can we evidence improvement in quality of life when successfully treating ED? Chair: John Pryor, United Kingdom Speaker: Axel Fugl-Meyer, Sweden S-3 Satellite Symposium 12.30 - 13.30 Festsaal Connecting the Dots in ED Treatment: Erectile Function & Satisfaction Chair: John Mulhall, USA S-03-01 Welcome/Introductions John Mulhall, USA S-03-01 Treatment to Goal: Monitoring Response to ED Treatment John Mulhall, USA S-03-02 Hardness of Erection as a Treatment Goal: Recent Clinical Evidence Klaus-Peter Jünemann, Germany S-03-03 Connecting the Dots - Implications of the Consensus for Patients, Partners, and Physicians Michael Kirby, United Kingdom S-03-04 Closing Remarks/Question & Answer John Mulhall, USA sponsored by an educational grant of Pfizer Inc. 27 28 SCIENTIFIC PROGRAM Monday, 4 December 2006 I-1 Interactive Session 13.30 - 15.00 P-02-015 Risk of severe erectile dysfunction is higher in older, overweight men Serge Carrier, Canada A. Morales, I. Defoy P-02-016 Prevalence of neuropathic disturbances and their predictive value for erectile dysfunction in diabetic men Zdravko Kamenov, Bulgaria V. Christov, T. Yankova P-02-017 In vivo electrophysiology in the paraventricular nucleus: Correlations with erectile activity Kelly Allers, United Kingdom N. Richards, C. Wayman P-02-018 Sexual life quality of 10.161 subjects over 40 years old: Partial results Carmita Abdo, Brazil J. A. Abdo, M. E. Caetano Best Papers 13.30 - 15.00 Zeremoniensaal Surgery / Peyronie’s Chairs: Ignacio Moncada, Spain Juan Ignacio Martinez-Salamanca, USA P-2 Prothrombotic markers predict the presence of erectile dysfunction Charalambos Vlachopoulos, Greece K. Aznaouridis, C. Vasiliadou, K. Rokkas, N. Ioakeimidis, I. Dima, A. Askitis, C. Stefanadis Festsaal Female Sexual Health Chair: Kevan Wylie, United Kingdom Panel: Loukas Athanasiadis, Greece Lori Boul, United Kingdom Brian Danes, United Kingdom Emmanuele Jannini, Italy Ruth Hallam, United Kingdom Sue Nicol, United Kingdom B-2 P-02-014 Podium Session 13.30 - 15.00 Forum Pathophysiology of sexual dysfunctions Chairs: Javier Angulo Frutos, Spain Andreas Jungwirth, Austria P-02-011 P-02-012 P-02-013 Isolated hypertriglyceridaemia and erectile dysfunction: Is there a significant correlation? Sudhanshu Chitale, United Kingdom S. Irving The metabolic syndrome and associated sexual dysfunction: Psychobiological correlates Giovanni Corona, Italy E. Mannucci, L. Petrone, R. Mansani, C. Schulman, G. Balercia, V. Chiarini, G. Forti, M. Maggi Erectile dysfunction is related to arterial stiffness and markers of systemic vascular inflammation and endothelial function in patients with metabolic syndrome Konstantinos Rokkas, Greece C. Vlachopoulos, N. Ioakeimidis, K. Aznaouridis, C. Vasiliadou, D. Tsekoura, K. Baou, A. Askitis, C. Stefanadis C-2 Instructional Course 13.30 - 15.00 Prinz-Eugen-Saal Testosterone Replacement Chair: John Dean, United Kingdom C-02-01 Epidemiology and diagnosis challenges Siegfried Meryn, Austria C-02-02 Metabolic consequences of androgen deficiency and benefits of treatment Geoffrey Hackett, United Kingdom C-02-03 Testosterone and the prostate Claude Schulman, Belgium C-02-04 Selecting a treatment regime John Dean, United Kingdom Treatment in practice: Case discussions Faculty and The Audience SCIENTIFIC PROGRAM Monday, 4 December 2006 R-1 Round Table 15.30 - 17.00 Zeremoniensaal The Ageing Couple Chair: Siegfried Meryn, Austria R-01-01 Menopause - effect on couples sexual function when treating ED Beatrice Cuzin, France R-01-02 Male menopause - fact or fiction? Antonio Aversa, Italy R-01-03 ED and treatment - impact on couples sexual function Siegfried Meryn, Austria R-01-04 Treating the ageing couple Jacques Buvat, France MP-2 Moderated Poster Session 15.30 - 17.00 Forum Pharmacology Chairs: Emre Akkus, Turkey Konstantinos Hatzimouratidis, Greece MP-02-084 A comparison of vardenafil and sildenafil: Treatment satisfaction among men with erectile dysfunction and cardiovascular risk factors, and their partners Eusebio Rubio-Aurioles, Mexico H. Porst, I. Eardley, I. Goldstein MP-02-085 Efficacy of tadalafil dosed once a day to treat erectile dysfunction in men with comorbid moderate or severe lower urinary tract symptoms secondary to benign prostatic hyperplasia Christian Stief, Germany C. P. Steidle, J. M. Kaufman, R. A. Feldman, M. C. Gittelman, K.-E. Andersson, K. Loughney, J. W. Hirman, B. Denes MP-02-086 Erection hardness and quality correlate with erectile function, emotional well-being, and treatment satisfaction: Double-blind, placebo-controlled multinational trial of Viagra® (Sildenafil Citrate) Andrzej Depko, Poland A. Kadioglu, W. Grohmann, I. Levinson, M. Carlsson, S. Collins MP-02-087 Clinical Experience with Invicorpâ at Good Hope Hospital ED Clinic 19962006 Geoffrey Hackett, United Kingdom F. Larsen MP-02-088 Vardenafil improves sexual function in men with erectile dysfunction and their female partners William Fisher, Canada R. Rosen, M. Mollen, G. Brock, G. Karlin, P. Pommerville, I. Goldstein, K. Bangerter, Z. Herman-Gnjidic, T. Taylor, L. Derogatis MP-02-089 Improvement in erection hardness for men with milder erectile dysfunction is associated with improvements in measures of psychosocial well-being Ates Kadioglu, Turkey W. Grohmann, A. Depko, I. Levinson, M. Carlsson MP-02-090 Therapeutic effect of combination of alagebrium and sildenafil on erectile function in diabetic rats Mustafa Faruk Usta, Turkey G. Sagdic, N. Gurbuz, A. Sanli, R. Gurkan, A. Baykal MP-02-091 Efficacy of sildenafil citrate treatment after re-instruction in normogonadal patients with sildenafil failed patients Murad Basar, Turkey A. Atan, A. Tuncel, D. Tuglu 29 30 SCIENTIFIC PROGRAM Monday, 4 December 2006 MP-02-092 A normal endothelium increases the therapeutic role of Tadalafil in vasculogenic erectile dysfunction Mario Mancini, Italy M. Guazzi, F. Nerva, G. Contalbi, G. M. Colpi MP-02-093 Vardenafil and Alfuzosin polypharmacotherapy for erectile dysfunction Vipan Bhatia, United Arab Emirates MP-02-094 Phosphodiesterase type 5 inhibitornaive men with erectile dysfunction can achieve completely hard and fully functional erections with Viagra® (Sildenafil Citrate) Suzanne Collins, USA V. Stecher, H. Wang MP-02-095 Vardenafil improves erectile function in men and treatment satisfaction in couples affected by erectile dysfunction previously untreated with pde5 inhibitors David Edwards, United Kingdom G. Hackett, O. Collins, J. Curram MP-02-096 Dapoxetine has no significant QT interval or other electrocardiographic effects in healthy men Nishit Modi, USA P. Staehr, M. Dresser, D. Rivas MP-02-097 Comparison the efficacies of sildenafil only to the sildenafil plus testosterone treatment after re-instruction in sildenafil failed normogonadal patients Ali Atan, Turkey M. M. Basar, A. Tuncel, D. Tuglu MP-02-098 Factors influencing continuation of tadalafil treatment for erectile dysfunction at 6 months: Results from the DETECT study Stefan Arver, Sweden P. Perimenis, H. Heidler, T. Roumeguere, M. Belger C-3 Instructional Course 15.30 - 17.00 Prinz-Eugen-Saal Basics in Ejaculatory Disorders Chair: Marcel D. Waldinger, The Netherlands C-03-01 Symptoms, definitions and classification Marcel D. Waldinger, The Netherlands C-03-02 Epidemiology and diagnosis Axel Fugl-Meyer, Sweden C-03-03 Non pharmacological perspectives in the treatment of ejaculatory disorders Tricia Barnes, United Kingdom C-03-04 Pharmacological treatment options Marcel D. Waldinger, The Netherlands C-03-05 Acquired PE due to thyroid dysfunction and prostatitis Emmanuele Jannini, Italy S-4 Satellite Symposium 17.00 - 18.30 Integrating Partners into Unrealistic or Mandatory? Festsaal ED Treatment: S-04-01 Welcome and introduction Annamaria Giraldi, Denmark S-04-02 Female Perspectives on Sexual Health Annamaria Giraldi, Denmark S-04-03 Understanding the Interactive Nature of ED: Female Perceptions Eusebio Rubio-Aurioles, Mexico S-04-04 Clinical Review of Vardenafil: Applications for Couple Interaction Carlo Bettocchi, Italy S-04-05 Question and Answer, Summary Annamaria Giraldi, Denmark sponsored by an educational grant of Bayer HealthCare AG ESSM Business Meeting 18.30 - 19.30 For members only Zeremoniensaal SCIENTIFIC PROGRAM Tuesday, 5 December 2006 ML-5 Master Lecture 08.00 - 08.30 R-2 Festsaal Round Table 10.00 - 11.30 Festsaal The ESAU Lecture Chair: Vincenzo Mirone, Italy More Hot Topics with PDE5 Inhibitors Chair: Antonio Martin Morales, Spain ML-05-01 R-02-01 Non-prescribed use of PDE5 inhibitors Antonio Martin-Morales, Spain R-02-02 Are there neurovascular protective effects of PDE5 inhibitors? John Mulhall, USA R-02-03 PDE5 and urogenital functions unanswered questions and future perspectives Petter Hedlund, Sweden ML-6 Testosterone Deficiency: Risks and Benefits of Testosterone Treatment Claude Schulman, Belgium Master Lecture 08.30 - 09.00 Festsaal The SMSNA Lecture Chair: Francesco Montorsi, Italy ML-06-01 Peyronie’s Disease Wayne Hellstrom, USA P-3 Podium Session 10.00 - 11.30 ML-7 09.00 - 09.30 Festsaal The ESSM Award Lecture Chair: Petter Hedlund, Sweden ML-07-01 S-5 Zeremoniensaal Master Lecture Female Sexual Health Chairs: Yoram Vardi, Israel Christina Damsted Petersen, Denmark P-03-019 Sexual distress in Danish women with type I and type II diabetes Annamaria Giraldi, Denmark E. Kristensen, J. Vibe-Petersen, L. Behrend, E. Hommel, L. F. Eplov P-03-020 Female sexual function after surgery for stress urinary incontinence: Transobturator Suburethral Tape (TOT) versus Tension-free Vaginal Tape Obturator (TVT-O) Henk Willem Elzevier, Netherlands H. Putter, R. C. M. Pelger, G. A. B Lycklama a Nijeholt P-03-021 Review of Potential Role of Bremelanotide (PT-141) in the Treatment of Female Sexual Dysfunction Michael A. Perelman, USA FSD - what have we learned from a decade of clinical research? Andrea Salonia, Italy Satellite Symposium 09.30 - 10.00 Zeremoniensaal A Critical Overview of Current Guidelines in LOH Chair: Petter Hedlund, Sweden Speaker: Francesco Montorsi, Italy sponsored by an educational grant of Solvay Pharmaceuticals GmbH 31 32 SCIENTIFIC PROGRAM Tuesday, 5 December 2006 P-03-022 Nasally applied testosterone rapidly increases the amygdala response to emotional stimuli in middle-aged women Guido van Wingen, The Netherlands S. Zylicz, S. Pieters, K. M. Petersson, C. Mattern, R. J. Verkes, G. Fernandez P-03-023 The Effect of a testosterone transdermal patch on hypoactive sexual desire disorder in postmenopausal women not receiving systemic estrogen therapy, The APHRODITE study J. Studd, United Kingdom C. Bouchard, R. Kroll, H. Koch, B. von Schoultz, S. Davis P-03-024 Sexual problems in the transition to menopause Judith Alder, Switzerland E. Leiser, J. Marti, J. Bitzer P-03-025 Epidemiology of dyspareunia in sexually active pre-menopausal women: Relationship to contraceptives Irwin Goldstein, USA K. Fugl-Meyer, A. Fugl-Meyer P-03-026 The prevalence of female sexual dysfunction in partners of men with premature ejaculation Kevin Hobbs, United Kingdom T. Symonds, L. Abrahams, K. May, M. Morris P-03-027 Endorsement of models of female sexual response and correlation with FSFI scores in a sample of registered nurses: The Nurses Sexuality Study Michael Sand, Germany P-03-028 Hypothalamic neuropeptides have functional receptors in the rat spinal cord (l4-s1) which may modulate female sexual function Lesley Wilson, United Kingdom C. Wayman, M. Jackson MP-3 Moderated Poster Session 10.00 - 11.30 Forum Basic Science - Physiology and Pathophysiology Chairs: Giovanni Corona, Italy Ulf Simonsen, Denmark MP-03-099 Expression of cyclic AMP-dependent protein kinase-1 isoforms in human cavernous arteries (HCA) and corpus cavernosum (HCC): Relation to vasoactive intestinal polypeptide-containing nerves and PDE4 Eginhard Waldkirch, Germany S. Ueckert, K. Langnäse, K. Richter, M. Sohn, U. Jonas, G. Wolf, K.-E. Andersson, C. G. Stief, P. Hedlund MP-03-100 Relationship between well-being and erectile function and autonomic variables in male with/without sexual dysfunction Tolga Dogru, Turkey O. M. Kocak, M. M. Basar, N. ErberkOzen, E. Batislam MP-03-101 The role of rho/rhokinase pathway in serotonin-induced contraction in diabetic and nondiabetic human corpus cavernosum Nergis Murat, Turkey B. C. Burak, O. Demir, S. Gidener, A. Esen MP-03-102 Increased levels of endothelin-1 as a marker of a generalized vascular disease manifested by vasculogenic erectile dysfunction Konstantinos Rokkas, Greece C. Vlachopoulos, N. Ioakeimidis, C. Vasiliadou, I. Dima, G. Antoniou, A. Askitis, C. Stefanadis MP-03-103 Correlation of penile Doppler findings of arterial flow and severity of coronary artery disease Charalambos Vlachopoulos, Greece K. Rokkas, N. Ioakeimidis, C. Aggeli, G. Roussakis, D. Soulis, A. Askitis, A. Michailides, C. Stefanadis SCIENTIFIC PROGRAM Tuesday, 5 December 2006 MP-03-104 Erectile dysfunction is associated with increased aortic stiffness in patients with and without coronary artery disease Charalambos Vlachopoulos, Greece N. Ioakeimidis, K. Rokkas, A. Tsokanis, D. Adamopoulos, P. Xaplanteris, C. Fassoulakis, C. Stefanadis MP-03-105 Electrical activity in the ventromedial nucleus in vitro predicts lordosis behaviour Clair Booth, United Kingdom C. Wayman, M. Jackson MP-03-106 Exacerbated pressor response regulated by daily treatment with sildenafil in an animal model of metabolic syndrome Delphine Behr-Roussel, France A. Oudot, S. Compagnie, D. Gorny, O. Le Coz, J. Bernabé, C. Wayman, L. Alexandre, F. Giuliano MP-03-107 Investigation of TGF- Beta 1 levels in patients with Peyronie’s Disease (PD) Evsey Mazo, Russia L. Ivanchenko, M. Moufagued MP-03-108 Expression of messenger rna (mRNA) encoding for phosphodiesterase (PDE) isoenzymes in human female genital tissues Stefan Ückert, Germany P. Ellinghaus, K. Albrecht, U. Jonas MP-03-109 Sexual and erectile function after treatment of testicular cancer Jakob Lackner, Austria I. Märk, G. Schatzl, C. Kratzik, M. Marberger MP-03-110 Erectile dysfunction may predict coronary artery disease: Relationship with coronary artery calcium scoring and erectile dysfunction severity Olider Yaman, Turkey O. Gulpinar, T. Hasan, C. Ozdol, S.F. Ertas, E. Ozgenci MP-03-111 The quality of erection questionnaire for the assessment of erection quality, hardness, and duration in men with erectile dysfunction Vera Stecher, USA S. Collins, H. Wang MP-03-112 Factors associated to bother from sexual problems: Results from the hoppes study Paraskevi-Sofia Kirana, Greece M. Fridakis, K. Moisidis, R. Rosen, J. McKinlay, D. Hatzichristou MP-03-113 Influence of concomitant diseases on the sexual quality of life of patients with erectile dysfunction and their partners Pedro R. Gutierrez, Spain M. Mas, P. Hernandez, E. J. Sanz, O. Cardenosa, A. Munoz, M. Artes C-4 Instructional Course 10.00 - 11.30 Prinz-Eugen-Saal Psychotherapies in Premature Ejaculation Chair: Tricia Barnes, United Kingdom C-04-01 Cognitive Behavioural Approaches in the Treatment of Premature Ejaculation Mehmet Sungur, UK C-04-02 Treatment Resistant cases of Premature Ejaculation : A Psychoanalytic Approach Marie Chevret Measson, France C-04-03 An Integrative Approach to Premature Ejaculation - Emotional and Relationship Perspectives Chiara Simonelli, Italy CP-2 Point Counterpoint Session 11.30 - 12.00 Festsaal PDE5 inhibitors in Patients with Premature Ejaculation but not ED? Chair: Hans Hedlund, Norway Pro-Speaker: Alberto Briganti, Italy Con-Speaker: Marcel D. Waldinger, The Netherlands 33 34 SCIENTIFIC PROGRAM Tuesday, 5 December 2006 HS-1 History Session 11.30 - 12.00 P-4 Zeremoniensaal Freud to Steinach - From the History of Sexual Medicine in Vienna Chair: Dirk Schultheiss, Germany S-6 13.30 - 15.00 From Clinical Study Optimizing ED Therapy P-04-029 Safety and efficacy of orally inhaled apomorphine (VR004) in the treatment of erectile dysfunction Alan Riley, United Kingdom F. Morgan, M. Main, M. Newton, J. Kirkpatrick P-04-030 Increased erection hardness in men treated with flexible-dose Viagra® (Sildenafil Citrate) in a double-blind, placebo-controlled multinational trial with open-label extension Ates Kadioglu, Turkey W. Grohmann, A. Depko, I. Levinson, F. Sun, S. Collins P-04-031 Daily tadalafil improves endothelial and erectile function in men with systemic sclerosis Antonio Aversa, Italy M. Proietti, R. Bruzziches, C. Rossi, E. A. Greco, C. Letizia, F. Salsano, G. Spera P-04-032 Daily treatment with sildenafil reverses endothelial dysfunction and oxidative stress in an animal model of metabolic syndrome Delphine Behr-Roussel, France A. Oudot, S. Caisey, O. Le Coz, D. Gorny, J. Bernabe, C. Wayman, L. Alexandre, F. Giuliano P-04-033 Differential effects of 2-week treatment with atorvastatin or elocalcitol, rhoa/rho-kinase signalling modulators, on erectile function and sildenafil responsiveness in spontaneously hypertensive rats Annamaria Morelli, Italy X.-H. Zhang, S. Filippi, L. Vignozzi, S. Mungai, L. Adorini, M. Maggi Festsaal to Clinical Practice: Welcome Gerald Brock, Canada S-06-01 Clinical studies and observational studies: Their relative merits for clinical practice? Josép Maria Haro, Spain S-06-02 Comparing efficacy of and preference for Sildenafil Citrate and Tadalafil Gerald Brock, Canada S-06-03 Alternative Dosing Regimens with Tadalafil in Clinical Studies David Ralph, UK Questions and Closing Remarks sponsored by an educational grant of Lilly ICOS LLC I-2 Interactive Session 13.30 - 15.00 Festsaal Ejaculatory Disorders Chair: Geoffrey Hackett, United Kingdom Panel: Vincenzo Mirone, Italy Eugen Plas, Austria Jens Sönksen, Denmark Ragnar Stien, Norway Zeremoniensaal Pharmacology Chairs: Dimitrios Hatzichristou, Greece Eric Wespes, Belgium Satellite Symposium 12.30 - 13.30 Podium Session SCIENTIFIC PROGRAM Tuesday, 5 December 2006 P-04-034 P-04-035 P-04-036 P-04-038 MP-4 A comparison of vardenafil and sildenafil: Preference among men with erectile dysfunction and cardiovascular risk factors Hartmut Porst, Germany E. Rubio-Aurioles, I. Eardley, I. Goldstein Consistent benefits with vardenafil regardless of age, prior pde-5 use or geographical location in men with erectile dysfunction and their partners: the COUPLES-project Ray Rosen, USA W. Fisher, M. Beneke, M. Homering, T. Evers Tadalafil administered once a day is efficacious and well tolerated for treating erectile dysfunction in men with diabetes mellitus Gerry Brock, Canada J. Buvat, M. Gambla, D. Hatzichristou, D. Lording, L. Rose, E. R. Aurioles, G. Spera, S.-Y. Liang, L. Frumkin Randomized, double-blind, placebocontrolled, at-home study of intranasal bremelanotide (PT-141) in men with erectile dysfunction with and without diabetes mellitus Wayne Hellstrom, USA M. Gittelman, N. Zinner, T. Hallam, R. Harning, D. Dworaczyk, R. Rolleri Moderated Poster Session 13.30 - 15.00 Forum Surgery, Peyronie’s Disease and Priapism Chairs: Christian Stief, Germany Suks Minhas, United Kingdom MP-04-114 A trauma of the penis as an etyological factor of Peyronie disease Yuriy Gurzhenko, Ukraine MP-04-115 Geometrical principle in the surgical treatment of Peyronie’s disease - egydio procedure: Belgrade experience Sava Perovic, Serbia and Montenegro M. Djordjevic, R. Djinovic, S. Sansalone MP-04-116 The role of MRI in the management of ischaemic priapism Paul Anderson, United Kingdom C. Allen, S. Minhas, D. Ralph MP-04-117 Andrologic aspects of the exstrophy-epispadias-complex after functional bladder reconstruction Anne Ebert, Germany M. Bals-Pratsch, B. Seifert, W. H. Roesch MP-04-118 Phalloplasty using of radial forearm flap with the reimplantation of distal fragment of penis Mikhail Sokolschik, Russia S. Gagarina, Y. Vasiev, R. Petrovich, I. Sadakova MP-04-119 The 10 years experience in grafting corporoplasty Know-how and qualityfactors. Keep spacers patches Patteo Paradiso, Italy O. Sedigh, G. L. Milan, M. E. Graziano, U. Ferrando MP-04-120 Penile fracture. Differential diagnosis, management and outcome Jorge Cabral Ribeiro, Portugal MP-04-121 Emblematic case of penile ventral deformation (120°) with ED. Albuginea modeling and straithening with penile Implantation Omid Sedigh, Italy M. Paradiso, M. E. Graziano, F. Liberale, U. Ferrando MP-04-122 Radial artery urethroplasty in phalloplasty Christopher Nim, United Kingdom D. Ralph MP-04-123 Long term results of primary penile venous leakage surgery with crural ligation in men with erectile dysfunction at a single university hospital Selahittin Cayan, Turkey D. Acar, E. Akbay MP-04-124 The use of dermal fillers in Andrology Giulio Garaffa, United Kingdom S. Minhas, P. Kell, D. Ralph 35 36 SCIENTIFIC PROGRAM Tuesday, 5 December 2006 MP-04-125 Penile enlargement corporoplasty with prosthetic implant: Original reconstructive technique for sexual and erectile dysfunction Fulvio Colombo, Italy A. Cazzaniga, A. Guarneri, A. L. Romano, E. Austoni MP-04-126 Outcome from penile prostheses revision surgery Paul Anderson, United Kingdom V. Agarwal, F. Soden, D. Ralph, S. Minhas MP-04-127 Long term efficacy and patient satisfaction of plication corporoplasty in congenital penile curvature Giorgio Franco, Italy A. Cavaliere, G. Del Vecchio, D. Dente, N. Almoghalis, F. D’Amico MP-04-128 Hypoxia-inducible factor-alpha is elevated in Peyronie’s disease plaques - hypoxia is an aetiological factor? Vineet Agrawal, United Kingdom P. Munson, S. Minhas, A. Freeman, D. Ralph C-5 Instructional Course 13.30 - 15.00 B-3 15.30 - 17.00 C-05-01 Anatomy and physiology Ferdinando Fusco, Italy C-05-02 Assessment and physical examination Bert-Jan de Boer, The Netherlands C-05-03 Treatment Ian Eardley, United Kingdom Zeremoniensaal Female Sexual Health Chairs: Andrea Salonia, Italy Annamaria Giraldi, Denmark P-5 Podium Session 15.30 - 17.00 Forum Ejaculatory Disorders Chairs: Juza Chen, Israel Stefan Arver, Sweden P-05-039 Dapoxetine acts supraspinally to inhibit ejaculatory reflex in anaesthetised rats Pierre Clement, France J. Bernabe, P. Gengo, P. Denys, M. Laurin, L. Alexandre, F. Giuliano P-05-040 Vibratory ejaculation and home insemination in 140 spinal cord injured men and their partners Jens Sönksen, Denmark D. Löchner-Ernst, D. Ohl P-05-041 Dapoxetine for the treatment of premature ejaculation: Low incidence of sexual side effects Ridwan Shabsigh, USA J. Pryor, F. Tesfaye P-05-042 Open pilot studies and a multi-centre, open-label, parallel-group study of the Sexual Assessment Monitor (SAM) in patients with premature ejaculation W. Dinsmore, Ireland D. Ralph, P. Kell, K. Wylie, J. Dean, C. Novak, J. Wyllie, M. Wyllie P-05-043 Retarded ejaculation: A psycho-physiological approach forassessment and management in 22 patients Ronen Rub, Israel M. Kreizman, J. Chen, P. Hegarty, N. Erlich Prinz-Eugen-Saal Basics in Erectile Dysfunction Chair: Ian Eardley, United Kingdom Best Papers SCIENTIFIC PROGRAM Tuesday, 5 December 2006 P-05-044 P-05-045 P-05-046 P-05-047 P-05-048 Further validation of the newly developed Premature Ejaculation Diagnostic Tool Tara Symonds, United Kingdom M. Perelman, S. Althof, F. Giuliano, M. Martin, L. Abraham, A. Crossland, M. Morris, K. May TEMPE, a novel aerosol delivery form of lidocaine-prilocaine for the treatment of premature ejaculation Mike Wyllie, United Kingdom W. Dinsmore, G. Hackett, D. Goldmeier, M. Waldinger, J. Dean, P. Wright, M. Callander, K. Wylie, C. Novak, C. Keywood, P. Heath Effects of selective phosphodiesterase inhibitors on the contractile responses of isolated human seminal vesicle tissue Stefan Ückert, Germany S. Bazrafshan, M. Mayer, U. Jonas, C. Stief Does sildenafil alleviate premature ejaculation - a double blind, placebo control cross-over study Juza Chen, Israel Y. Bar-Yosef, M. Sofer, N. J. Mabjeesh, A. Greenstein, H. Matzkin Comparison of sertralin vs. sertralin+PDE5 inhibitors in the treatment of premature ejaculation Emre Akkus, Turkey B. Alici, H. Ozkara, B. Onal, H. Hattat C-6 Instructional Course 15.30 - 17.00 Prinz-Eugen-Saal Advanced ED Management - from Pharmacotherapy to Penile Implant Chairs: Hartmut Porst, Germany Michael Sohn, Germany C-06-01 Conservative management of the difficult to treat ED patient Hartmut Porst, Germany C-06-02 Surgical treatment of the difficult to treat ED patient Michael Sohn, Germany C-06-03 Injection therapies and vacuum devices Hartmut Porst, Germany S-7 Satellite Symposium 17.00 - 18.00 Zeremoniensaal Integrated Management of HSDD. Intrinsa, a New Therapeutic Option Chair: John Dean, UK S-07-01 Revealing the faces of Hypoactive Sexual Desire Disorder Johannes Bitzer, Switzerland S-07-02 Intrinsa - completing your treatment choices Anneliese Schwenkhagen, Germany sponsored by an educational grant of Procter & Gamble Pharmaceuticals 37 38 SCIENTIFIC PROGRAM Wednesday, 6 December 2006 I-3 Interactive Session 08.00 - 09.30 Podium Session 08.00 - 09.30 Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat Linda Vignozzi, Italy A. Morelli, S. Filippi, M. Marini, G. B. Vannelli, G. Forti, M. Maggi P-06-054 Low-dose sildenafil improves recovery of erectile function after nervesparing radical prostatectomy Andreas Bannowsky, Germany H. Schulze, C. van der Horst, S. Hautmann, K.-P. Jünemann P-06-055 A prospective, randomized, placebo-controlled multicentre study on the effectiveness of oral sildenafil in preventing postoperative erectile dysfunction following radical retropubic prostatectomy Pekka Kunelius, Finland J. Häkkinen, P. Ohtonen P-06-056 Long-term follow-up (fu) of intracavernous (ic) injection therapy for erectile dysfunction (ed) Andrea Salonia, Italy L. Barbieri, A. Gallina, A. Briganti, F. Deho, G. Zanni, N. Suardi, F. Pellucchi, F. Abdullah, P. Rigatti, F. Montorsi P-06-057 The use of the IIEF-5 questionnaire for evaluation of erectile dysfunction following nerve-sparing radical prostatectomy Maarten Albersen, Belgium S. Joniau, H. van Poppel, H. Claes P-06-058 Reconsidering the use of IIEF questionnaire in evaluating the preoperative erectile function status of patients undergoing radical prostatectomy Stefanos Papadoukakis, Germany D. Kusche, B. Löppenberg, J. U. Stolzenburg, M. C. Truss Festsaal Erectile Dysfunction Chair: Edoardo S. Pescatori, Italy Panel: Juza Chen, Israel Fulvio Colombo, Italy Konstantinos Hatzimouratidis, Greece Trygve Talseth, Norway Walter Stackl, Austria P-6 P-06-053 Zeremoniensaal Erectile Dysfunction following Prostatectomy Chairs: Bob Djavan, Austria Alberto Briganti, Italy Radical P-06-049 Identification of predictors of functional outcome of open nervesparing radical prostatectomy S. Joniau, Belgium H. van Poppel, H. Claes, M. Albersen P-06-050 Severe drop-off rate from the treatment for erectile dysfunction in noncounselled patients after bilateral nerve sparing radical prostatectomy (bnsrrp) Andrea Salonia, Italy A. Gallina, G. Zanni, A. Briganti, F. Deho, N. Suardi, A. Sacca, U. Capitanio, G. Petralia, P. Rigatti, F. Montorsi P-06-051 The impact of nerve sparing surgery and the recovery of erections on penile shortening after radical prostatectomy Mario Galzerano, Italy C. Magnani, L. Castigli, N. Mondaini, P. Gontero P-06-052 Histological alterations in cavernous tissue after radical prostatectomy Paolo Verze, Italy F. Iacono, C. Imbimbo, F. Fusco, N. Longo, F. Mangiapia, V. Mirone SCIENTIFIC PROGRAM Wednesday, 6 December 2006 C-7 Instructional Course 08.00 - 09.30 B-4 Forum Basics in Female Sexual Health Chair: Ilan Gruenwald, Israel C-07-01 Definitions, prevalence and riskfactors Kerstin Fugl-Meyer, Sweden C-07-02 Diabetes and FSD Paul Enzlin, Belgium C-07-03 Non-pharmacological treatment Agnes Kocsis, United Kingdom C-07-04 Pharmacological treatment Ilan Gruenwald, Israel ML-8 P-07-059 Total phalloplasty using musculocutaneous latissimus dorsi free transfer flap - penile size according to the patients wish Sava Perovic, Serbia and Montenegro M. Djordjevic, M. Bumbasirevic, R. Djinovic, S. Sansalone P-07-060 Efficacy of Injectable mixed collagenase subtypes for Peyronie’s disease: Treatment-related improvements in sexual function and sexual satisfaction Gerald Jordan, USA P-07-061 Tight-skin (Tsk) mice as new experimental model of Peyronie’s disease Raffaella Sorrentino, Italy F. Fusco, A. Palmieri, R. D’Emmanuele di Villabianca, D. Arcaniolo, P. Verze, V. Mirone P-07-062 Penile prosthesis in patients with Peyronie’s disease: Our tips and tricks Peter Scheplev, Russia I. Danilov, B. Gvasaliya, N. Garin P-07-063 Total phallic construction using the forearm free flap Giulio Garaffa, United Kingdom N. Christopher, D. Ralph The ESDA Experience Chair: Antoine Lemaire, France R-03-01 The role of the European Alliance Milly Lemos, Spain R-03-02 The relation between ESDA and scientific societies Stamatis Papacharitou, Greece R-03-03 Why patients with sexual difficulties do not take medical advice? Antoine Lemaire, France Zeremoniensaal Surgery and Peyronie’s Disease Chairs: Stephane Droupy, France Edoardo Austoni, Italy Festsaal Zeremoniensaal Podium Session 10.30 - 12.00 Round Table 10.00 - 10.30 Festsaal Ejaculatory and Orgasmic Disorders Chairs: Francois Giuliano, France Kerstin Fugl-Meyer, Sweden Master Lecture Drug Misuse and Sexual Function the Case of Heroin Addiction Chair: Stefan Ückert, Germany Speaker: Antonio Palha, Portugal R-3 10.30 - 12.00 P-7 10.00 - 10.30 Best Papers 39 40 SCIENTIFIC PROGRAM Wednesday, 6 December 2006 P-07-064 Implantation of inflatable penile prosthesis without dilatation of the corpora. Analysis of 50 consecutive cases Ignacio Moncada, Spain J. Jara, J. I. Martinez-Salamanca, R. Cabello, J. I. Monzo, C. Hernandez P-07-065 Concurrent dual inflatable penile prosthesis and incontinence implant (AMS-1500) after radical surgery. Transversal incision approach. Our preliminary experience Omid Sedigh, Italy M. Paradiso, M. E. Graziano, R. Rossi, U. Ferrando P-07-066 The role of preoperative MRI in revision penile implant surgery C. Li, United Kingdom P. Anderson, D. Ralph, S. Minhas P-07-067 Infection rate after implantation of three-component penile prosthesis using a new pre- and postoperative protocol: Short term follow-up Federico Deho, Italy G. Henry, A. Salonia, A. Briganti, G. Zanni, G. Savoca, F. Abdollah, R. Matloob, P. Rigatti, F. Montorsi P-07-068 MP-5 Frenular grafting - An alternative to circumcision Giulio Garaffa, United Kingdom O. Keyes, S. Minhas, N. Christopher, D. Ralph Moderated Poster Session 10.30 - 12.00 Forum General Issues in Sexual Medicine Chairs: Nuno Monteiro Pereira, Portugal Beatrice Cuzin, France MP-05-129 Plasma levels of dihydrotestosterone remain in the normal range in men treated with long-acting parenteral testosterone undecanoate Aksam Yassin, Germany F. Saad MP-05-130 Elevation of Asymmetrical Dimethylarginine (ADMA) in men with erectile dysfunction and metabolic syndrome Safar Gamidov, Russia E. Mazo, V. Iremashvili MP-05-131 Erection hardness is critical for good sex and a healthy relationship: The global better sex survey Irwin Goldstein, USA K.-P. Juenemann, J. P. Mulhall, V. Stecher MP-05-132 Evolution with age of thoughts and views on sexual function & relationship in the 50+ population in Belgium Hubert Claes, Belgium H. van Poppel MP-05-133 Is there a link between erection hardness and overall health? Results of the global better sex survey Rosie King, Australia V. Lehmann, I. Levinson MP-05-134 Clinical characteristics of erectile dysfunction patients with and without metabolic syndrome Evsey Mazo, Russia S. Gamidov, V. Iremashvili MP-05-135 Erectile dysfunction and men’s health: Developing a comorbidity risk calculator Ridwan Shabsigh, USA M. Sand MP-05-136 Socio-economic factors and sexual dysfunction in both genders results of the crossover-study „The Cologne 20.000 community survey“ Joanna Beate Korda, Germany K. Motia-Sharei, M. Braun, H. Christ, M. Hellmich, U. Engelmann MP-05-137 NPT-test: How to reduce the false positives? Fulvio Colombo, Italy A. L. Romano, C. Guerrer, A. Guarneri, E. Austoni SCIENTIFIC PROGRAM Wednesday, 6 December 2006 MP-05-138 Does postejaculatory early voiding cause to nonbacterial prostatitis? Ali Atan, Turkey M. M. Basar, A. Tuncel, Y. Aslan MP-05-139 The importance of and satisfaction with sex in Europe: Regional analysis of the global better sex survey Francois Giuliano, France K.-P. Juenemann, M. Kirby, I. Levinson MP-05-140 Severe obstructive sleep apnea syndrome is associated with female sexual dysfunction Mustafa Delibas, Turkey Z. Z. Ucar MP-05-141 Public-awareness does not promote a shortening of the delay in first seeking medical help for erectile dysfunction (ed) in the pde5-is era. Preliminary results at single major tertiary academic centre Andrea Salonia, Italy F. Pellucchi, R. Castillejos Molina, A. Briganti, F. Deho, A. Gallina, G. Zanni, N. Suardi, P. Rigatti, F. Montorsi 10th Congress of the European Society for Sexual Medicine 25 - 28 November 2007 Lisbon • Portugal www.essm.org MP-05-142 Time effect on potency in post-radical cystectomy patients: Subjective and objective evaluation Ehab Hekal, Egypt A. Mesbah, M. El-Bahnasawy, A. El-Assmy, M. Abdel-Latif, A. Shaaban MP-05-143 How to improve the quality of life at male population over 50 years old with erectile dysfunction Daniel Porav-Hodade, Romania N. Crisan, B. Feciche, Z. A. Mihaly, I. Coman See you in LISBON 2007 Closing Remarks 12.00 - 12.30 Festsaal 41 42 POSTER PRESENTATIONS Monday, 4 December Wednesday, 6 December 2006 The poster exhibition will be located at the Gardehalle I and II next to the main meeting halls and the registration counter on the ground floor of the Vienna Hofburg. The poster exhibition is open to all conference delegates on: The moderated posters will be located in front of the Forum at the Gardehalle I and II or in the Forum where the moderated poster session will take place. The posters will be changed daily in the room according to the sessions. Monday, 4 December 2006 09.00 h - 17.30 h Tuesday, 5 December 2006 09.00 h - 17.30 h Wednesday, 6 December 2006 09.00 h - 12.30 h Interested participants can meet the authors for discussions of their poster presentation during the following time: The unmoderated posters will be arranged according to topics and will be numbered within these topics and will be set up for the whole period of the congress in the Gardehalle I and II. The Gardehalle I and II are directly situated in front of the Forum. Monday, 4 December 2006 Tuesday, 5 December 2006 PP-01 15.00 h - 15.30 h 15.00 h - 15.30 h Poster Presentation Pharmacology PP-01-144 Does treatment with sildenafil improve quality of sexual life in a group of patients without sexual dysfunction? Interim analysis Ilan Gruenwald, Israel O. Massarwa PP-01-145 Treatment of post radical prostatectomy (PRP) sexual dysfunction with combined therapy of sildenafil and intracavernosal alprostadil (pge1) John Vlachiotis, Greece D. Petsis, G. Perlepes, N. Zozas, A. Tsidavis PP-01-146 Alfuzosin pharmacotherapy for primary premature ejaculation Vipan Bhatia, United Arab Emirates PP-01-147 Factors Influencing Preference for Tadalafil and Sildenafil Citrate (Sildenafil) in a Crossover Study Treating Erectile Dysfunction in Men Naïve to Phosphodiesterase 5 Inhibitor Therapy Ian Eardley, United Kingdom F. Montorsi, M. Chan, K. Loughney, G. M. Vail, A. Beardsworth PP-01-148 Tadalafil improves psychological aspects of sexual life in patients formerly treated by short-acting ED medication Juha Koskimaki, Finland M. Leinonen, A. Cameron, P. Saloranta, E. S. Leinonen POSTER PRESENTATIONS PP-01-149 PP-01-150 PP-01-151 PP-01-152 PP-01-153 PP-01-154 The Efficacy and Safety of tadalafil 10mg and 20mg in Japanese men with erectile dysfunction (ed) and a comparison of tadalafil doses in Japanese men with severe ed Yasusuke Kimoto, Japan K. Nagao, K. Marumo, A. Tsujimura, N. Ishii, K. Fujimoto, T. Imaoka, D. Stothard, S. Watts, J. McGill, S. Kamidono Treatment patterns over 6 months with PDE5 inhibitors in the erectile dysfunction observational study (EDOS) Anthony Beardsworth, USA A. Martin-Morales, A. von Keitz, D. Hatzichristou, A. Riley Satisfaction with erection hardness and overall sexual experience in men with Erectile Dysfunction (ED) treated with tadalafil Wayne Hellstrom, USA I. Moncada, D. J. Ralph, V. Mirone, M. Sotomayor, D. Stothard, S. Watts, A. Beardsworth Evaluation of the treatment results and adaptation to treatment in the PDE5 inhibitor therapy among erectile dysfunction patients Sertac Cimen, Turkey O. Demir, G. Aslan, A. Esen Erectile dysfunction and anxiety: The role of escitalopram. A preliminary study Giorgio Corretti, Italy I. Baldi Long-term administration of Udenafil, PDE type 5 inhibitor, helps to preserve erectile function in rats exposed to alcohol Gook Jun Ahn, Republic of Korea J. H. Sin, K. K. Kang, B. O. Ahn, M. Yoo PP-01-155 Effectiveness and satisfaction with tadalafil in patients changing PDE5 inhibitor treatment: Results from the DETECT study Thierry Roumeguere, Belgium S. Arver, T. Eliasson, M. Belger, H. Schmitt PP-01-156 The Real - Life Safety and Efficacy of Vardenafil (REALISE) Study - Results from Belgium Thierry Roumeguere, Belgium H. Claes, H. van Poppel, C. Schulman, H. Handel PP-01-157 The influence of vardenafil on quality sexual life in aging men with erectile dysfunction and diabetes mellitus Jacek Huk, Poland M. Fryczkowski, Z. Kaletka, M. Szwedowski PP-01-158 Attitudes of patients & physicians to the use of vardenafil in the Belgian population Hubert Claes, Belgium T. Roumeguere, H. van Poppel, C. Schulman, H. Landen PP-01-159 A sample analysis of patients in whom Phosphodiesterase Type-5 inhibitors treatment failed or was contraindicated Shawket Alkhayal, United Kingdom D. Backett, V. Lehmann PP-01-160 Efficacy and safety of sildenafil citrate in management of erectile dysfunction following radical retropubic prostatectomy Milos Brodak, Czech Republic P. Navratil, J. Pacovsky PP-01-161 Plasma levels of von Willebrand factor are lowered after treatment with 25 mg of sildenafil daily Angelis Konstantinopoulos, Greece S. Raptis, K. Gyftopoulos, K. Giannitsas, D. Spathas, P. Perimenis 43 44 POSTER PRESENTATIONS PP-01-162 Sildenafil reduces pudendal artery vascular resistance in the anaesthetised dog Chris Wayman, United Kingdom S. Hornby, A. Burden, N. Edmunds, J. Casey PP-01-169 Improvement of erectile function and fertility with Prelox. A placebocontrolled, double-blind, cross-over study Romil Stanislavov, Bulgaria V. Nikolova, P. Rohdewald PP-01-163 Pharmacokinetic-pharmacodynamic (PKPD) data demonstrates different erectogenic response-plasma exposure relationships for sildenafil, tadalafil, vardenafil, UK-343,664 & UK-357,903 Chris Wayman, United Kingdom S. Hornby, M. Price, L. Foster, A. Carter PP-01-170 Efficacy of sildenafil still maintained after 3 years of treatment despite a 2-month treatment pause Serge Carrier, Canada A. Morales, I. Defoy PP-01-171 Sildenafil improves depressive symptoms of men with ED and untreated depression not otherwise specified Helene Dugre, Canada S. Kennedy, P. D’Angelo, M. Sunderland, I. Defoy PP-01-172 Treatment satisfaction with sildenafil in a Canadian real-life setting Serge Carrier, Canada G. Brock, R. Casey, J.-E. Tarride, P. D’Angelo, S. Elliott, H. Dugre, C. Rousseau, I. Defoy PP-01-173 Men with erectile dysfunction may achieve a second erection with vardenafil, in a home setting Ray Rosen, USA J. McMurray, K. Bangerter, A. Mazzu PP-01-174 The in-vivo and in-vitro effects of vardenafil on corpus cavernosal smooth muscle relaxation in diabetic rabbits David Lau, United Kingdom C. Thompson, D. Mikhailidis, F. Mumtaz PP-01-175 Effectiveness and patient satisfaction with 6 months tadalafil treatment: Results from the DETECT study Benny Verheyden, Belgium T. Roumeguere, A. Bitton, E. Roos, M. Belger, H. Schmitt PP-01-164 Results of the use of vardenafil in “non-demand” regimen Andrey Vinarov, Russia N. Akhvlediani PP-01-165 The Real-Life Safety and Efficacy of Vardenafil (REALISE)? An international post-marketing surveillance study: Pooled results from 11 European countries Jürgen Zumbe, Germany H. van Ahlen, Z. Kopa, F. Trinkler, H. Landen PP-01-166 PP-01-167 PP-01-168 A comparison of vardenafil and sildenafil: Diary-recorded outcomes in men with erectile dysfunction and cardiovascular risk factors Eusebio Rubio-Aurioles, Mexico H. Porst, I. Eardley, I. Goldstein In a clinical setting using VSS, men with ED may achieve a second erection with vardenafil Ray Rosen, USA J. McMurray, K. Bangerter, A. Mazzu Erection hardness correlates positively with score on the quality of erection questionnaire (qeq): A double-blind, placebo-controlled multinational trial of flexible-dose Viagra® (Sildenafil Citrate) Andrzej Depko, Poland A. Kadlioglu, W. Grohmann, I. Levinson, F. Sun, S. Collins POSTER PRESENTATIONS PP-02 Poster Presentation PP-02-183 Preliminary results of post radical prostatectomy (prp) penile length John Vlachiotis, Greece D. Petsis, G. Perlepes, K. Spiliopoulos, A. Tsidavis PP-02-184 Sexual function in rats with testicular dysgenesis Konstantinos Karakitsios, Greece H. Kawamura, N. Pardalidis, E. Grameniatis, D. Baltogiannis, N. Sofikitis PP-02-185 The padam and expression of genes of several proliferation factors Alexander Pechersky, Russia O. Loran, V. Pechersky, M. Vonsky, A. Mittenberg, V. Semiglazov PP-02-186 The padam and regulation of the pulse mode of incretion of some hormones Alexander Pechersky, Russia V. Semiglazov, O. Loran, A. Karpischenko, V. Pechersky, V. Mazurov Risk factors, Hormones and Epidemiology PP-02-176 PP-02-177 Effects of hyperbaric oxygen therapy (HOT) on total testosterone (TT) blood serum concentration Giandomenico Passavanti, Italy V. Pizzuti, M. Carlucci, M. Brauzzi, P. Tanasi, R. Pagni, E. Norgini, R. Paolini, A. Aloisi Erectile dysfunction severity might be associated with poor cardiovascular prognosis in diabetic men Dan Justo, Israel I. Uri, Y. Arbel, M. Swartzon, S. Galor, R. Heruti PP-02-178 The prevalence of erectile dysfunction and its risk factors among nearly 10,000 men ages 25-55 years Dan Justo, Israel T. Shochat, S. Galor, R. Heruti PP-02-179 The effect of coronary artery bypass surgery on erectile function and related quality of life Matthew Hotston, United Kingdom R. Jones, G. Angelini, J. Jeremy, R. Persad PP-02-187 Correlation of aortic stiffness with severity of erectile dysfunction Nikolaos Ioakimidis, Greece C. Vlachopoulos, K. Rokkas, A. Tsokanis, N. Alexopoulos, C. Fassoulakis, A. Askitis, C. Stefanadis PP-02-180 Early rehabilitation & nerve sparing cystectomy. Is there any value? Ehab Hekal, Egypt A. Mesbah, M. El-Bahnasawy, A. ElAssmy, M. Abdel-Latif, A. Shaaban PP-02-188 PP-02-181 The realtionship between chronic obstructive pulmonary disease and erectile dysfunction: A comparative study Mustafa Faruk Usta, Turkey O. Ozbudak, A. Cilli, E. Guntekin, T. Koksal, T. Ozdemir Contraction and relaxation response of rabbit corpus cavernosum to partial bladder outlet obstruction: A direct comparison of 2- and 4-week Omer Demir, Turkey E. C. Esen, N. Murat, G. Aslan, S. Gidener PP-02-189 Patient preferences in treatment of erectile dysfunction after cryoablation of prostate for prostate cancer Leonid Lobik, Israel M. Hassan, D. Shumalinsky, D. Kesari, A. Paz, S. Kravchick, S. Cytron PP-02-182 ED: A cue for wider health risk assessments? Wendy Hurn, United Kingdom D. Rutherford, R. Etherington, P. Aslet, V. Griffiths 45 46 POSTER PRESENTATIONS PP-02-190 Erectile dysfunction obesity and metabolic syndrome - A multicenter study Aristomenis Gekas, Greece C. Konstantinidis, P. Kartsaklis, I. Palaiodimos, S. Andreadakis, N. Kalogeropoulos, D. Baltogiannis, N. Sofikitis PP-02-197 The role of sexual dysfunctions in inducing the use of drug in males: Preliminary results Giuseppe La Pera, Italy F. Peris, A. Carderi, Z. Marianantoni, S. Livi, T. Macchia PP-02-191 Premature ejaculation treated with sildenafil. A multicenter study Sotrios Andreadakis, Greece C. Konstantinidis, P. Kartsaklis, I. Palaiodimos, A. Gekas, D. Delakas PP-02-198 Sexual dysfunction in obese patients Pinar Kadioglu, Turkey D. Ozgil Yetkin, A. Serap Yalin, K. Onem, A. Kadioglu PP-02-199 PP-02-192 Microvascular complications and diabetic neuropathy are more important risk factors for diabetic erectile dysfunction, than macrovascular disturbances. Zdravko Kamenov, Bulgaria V. Christov, T. Yankova Outcomes of testosteron therapy in impotent patients with metabolic syndrom and hypogonadism Murat Cakan, Turkey F. Demirel, M. Topcuoglu, U. Altug PP-02-200 Stable testosterone levels achieved with subcutaneous testosterone injections Michael Greenspan, Canada PP-02-201 Sexual problems in Romanian active male population Nicolae Calomfirescu, Romania S. Fiica, C. Belinski, D. Gaita, D. L. Bucuras, A. Cambosie, M. Mota, A. Bulai, A. Study Group PP-02-202 Testosterone gel associated to tadalafil in the therapy of diabetic patients affected by erectile deficit Enrico Spera, Italy M. Scarfini, E. Vannozzi, A. De Carolis PP-02-203 The recovery of sexual function in patients with prostate cancer, obtaining antiandrogen therapy: Use of vacuum devices and PDE5 inhibitors Maksim Romanyuk, Ukraine I. Gorpinchenko, S. Shamraev PP-02-204 Early therapy following nerve sparing radicalprostatectomy (rp): Improvement with combination alprostadil + oral sildenafil Marco Bitelli, Italy A. Zucchi, G. Virgili, E. Spera, M. Pietrantuono, M. Valitutti, G. Vespasiani PP-02-193 PP-02-194 PP-02-195 PP-02-196 Combined reporting of functional and oncological results following open radical prostatectomy using the �Salomon-score’. Steven Joniau, Belgium M. Albersen, H. van Poppel, H. Claes Testosterone and erectile function in hypogonadal men unresponsive to PDE5 Inhibitors: Results from an open-label uncontrolled study Hubert Claes, Belgium H. van Poppel A comparison of ncep-atp-iii and idf metabolic syndrome definitions with relation to metabolic syndrome associated sexual dysfunction Giovanni Corona, Italy E. Mannucci, L. Petrone, F. Lotti, A. D. Fisher, C. Schulman, G. Balercia, G. Forti, M. Maggi An androgen-dependent PDE5 activity in bladder might contribute to LUTS Sandra Filippi, Italy A. Morelli, P. Sandner, B. Fibbi, R. Mancina, M. Marini, M. Gacci, L. Vignozzi, G. B. Vannelli, M. Carini, G. Forti, M. Maggi POSTER PRESENTATIONS PP-02-205 Sexual factors and prostate cancer Elena Longhi, Italy A. Salonia, R. Colombo, A. Briganti, P. Rigatti, F. Montorsi PP-02-206 In vitro effects of androgens on cyclic AMP and cyclic GMP levels in isolated human cavernous arteries (HCA) and corpus cavernosum (HCC) Eginhard Waldkirch, Germany S. Ueckert, C. Bruns, D. Schultheiss, M. Sohn, U. Jonas, K.-E. Andersson, C. G. Stief, P. Hedlund PP-02-207 PP-02-208 The erectile dysfunction in the alcohol drinking with low, medium and high risc Giuseppe Dachille, Italy V. Giovanni, G. Cardo, F. Maselli, M. Erinnio, G. M. Ludovico Is ED in patients with LUTS managed adequately in primary care? An audit of the current practice Sudhanshu Chitale, United Kingdom R. Collins, S. Hull, S. Irving PP-02-209 Frequency rate of erectile dysfunction in patients with arterial hypertension Iakov Kan, Russia PP-02-210 Sex hormones regulation in males with maldescendent testes Vitaliy Luchitskiy, Ukraine PP-02-211 PP-02-212 Erectile Dysfunction and South Asians: What determines whether participants seek healthcare? An ethnography centred in Oxfordshire and Sri Lanka David Edwards, United Kingdom Male Chlamydia self-testing Ian Banks, United Kingdom D. Wilkins PP-02-213 Ultrastructural characterization and immunohistochemical study of expression of Ang1, Ang2 and Tie-2 in corpus cavernosum of erectile dysfunction-prone rat models Pedro Vendeira, Portugal J. Santos, A. Cordeiro, A. Figueiredo, F. Godinho, I. Martins, H. Almeida, D. Neves PP-02-214 Testosterone is the therapeutical Bridge between Metabolic Syndrome and Erectile Dysfunction Farid Saad, Germany A. Yassin, R. Shabsigh, A. Traish, S. Kalinchenko, I. Eardley PP-02-215 Two modern modes of testosterone treatment compared: Transdermal testosterone gel and injectable long-acting testosterone undecanoate Aksam Yassin, Germany A. Haider, F. Saad PP-02-216 Does intracavernous rehabilitation of erectile function after nerve-sparing radical prostatectomy improve post-operative urinary stress-incontinence? Massimo Polito, Italy W. Giannubilo, M. Leone, G. d’Anzeo, G. Muzzonigro PP-02-217 Correlation between hemodinamic and clinical results of penile color Doppler ultrasound and risk factors for erectile dysfunction Carlo Bettocchi, Italy F. Boezio, V. Stellacci, G. Lucarelli, P. Ditonno, M. Battaglia, F. P. Selvaggi PP-02-218 Testosterone gel therapy for LUTS in male patients: A treatment option Fulvio Colombo, Italy A. Guarneri, A. L. Romano, E. Inneo, E. Austoni 47 48 POSTER PRESENTATIONS PP-02-219 The quality of life, sexuality and cognitive functions in patients diagnosed with PADAM Krzysztof Nowosielski, Poland V. Skrzypulec, A. Sipinski, A. Drosdzol PP-02-220 Histopathological proved prevention of post-prostatectomy cavernosal fibrosis with a PDE5 inhibitor Fabrizio Iacona, Italy D. Prezioso, P. Somma, S. Chierchia, R. Galasso, M. Di Martino PP-03 Poster Presentation Female sexual function and dysfunction PP-03-221 Correlation between FSFI scores and sexual dysfunction in male partners in a random sample of registered nurses: The Nurses Sexuality Study Michael Sand, Germany PP-03-222 Comparison of normative and menopausal women by the Brief Index of Sexual Functioning for Women (BISF-W) Heung-Yeol Kim, Republic of Korea C.-Y. Huh, D.-H. Bae, J.-S. Kang, D.-H. Kim, S.-Y. Hong, S.-T. Oh, K.-H. Lee, S.-H. Cho, S.-R. Kim, M.-H. Jung PP-03-223 Association of Women’s FSFI Scores and sexual dysfunction in male partners in a sample of registered nurses: The Nurses Sexuality Study Michael Sand, Germany PP-03-224 Sexual dysfunction in women with end stage renal disease and the investigation of risk factors Elife Kettas, Turkey F. Cayan, E. Akbay, A. Kiykim, S. Cayan PP-03-225 Prevalence of sexual disorders in women patients consulted urology clinics Adil Esen, Turkey H. Sicramaz, A. Sahin, O. Demir, D. Turan, E. Can PP-03-226 Risk factors of female sexual disorders Adil Esen, Turkey A. Sahin, H. Sicramaz, O. Demir, E. Bal, E. Can PP-03-227 The combined use of brachial artery flow mediated dilatation and carotid artery intima media thickness measurements is an alternative method to penile color doppler ultrasonography Gokhan Ucar, Turkey M. Secil, O. Demir, T. Demir, A. Comlekci, S. Caliskan, A. Esen PP-03-228 Penile Doppler findings of arterial flow in relation to vascular risk factors in patients with erectile dysfunction Konstantinos Rokkas, Greece C. Vlachopoulos, N. Ioakimidis, G. Antoniou, A. Tsokanis, A. Bratsas, A. Askitis, C. Stefanadis PP-03-229 Aortic stiffness and carotid intima media thickness are associated with penile Doppler findings in patients with vasculogenic erectile dysfunction Charalambos Vlachopoulos, Greece N. Ioakeimidis, D. Tsekoura, K. Rokkas, K. Aznaouridis, P. Pietri, A. Askitis, C. Stefanadis PP-03-230 Plasma concentration of asymmetric dimethylarginine (ADMA) in relation to vasculogenic erectile dysfunction in patients with and without coronary artery disease Nikolaos Ioakeimidis, Greece C. Vlachopoulos, C. Vasiliadou, K. Rokkas, A. Bratsas, G. Siasos, A. Askitis, C. Stefanadis PP-03-231 Temporal relationship between erectile dysfunction, cardiovascular disease and quality of life Lynette Hodges, United Kingdom M. Kirby, J. O’Donnell, D. Brodie POSTER PRESENTATIONS PP-03-232 Arterial stiffness predicts the level of the pharmacological induced erectile response in metabolic syndrome Vasile Coca, Romania PP-03-233 Sexual problems in hypertensive Turkish women in Turkey and Germany: A transcultural study Esma Demirezen, Turkey U. Henke, O. Sanli, A. Kadioglu PP-03-235 Prevalence of sexual dysfunction in women over 20 years of age in Istanbul Ergul Aslan, Turkey N. Kizilkaya Beji, I. Gungor, A. Kadioglu, B. Kucuk Dikencik PP-03-236 Relaxation of isolated rat vaginal strips and clitoral corpus cavernosum by PDE5 inhibitors Hanna Tinel, Germany J. Huetter, P. Sandner PP-03-237 Mild genital prolapse does not affect female sexual function Hyun Hee Cho, Republic of Korea J. Kim, J. Kim, M. Kim, Y. Rhew, D. Kwon, L. YoungTaek, H. Youn, M. Jung, C. Jun PP-03-238 The Effects of vaginal birth on postpartum sexual function Gulay Yildirim, Turkey N. Kizilkaya Beji, N. Comert, B. Kucuk Dikencik, A. I. Tekirdag, A. Kadioglu PP-03-239 Evaluation of female sexual function in patients underwent surgery for urogenital prolapse Alessandro Zucchi, Italy E. Costantini, A. Giannantoni, F. Fioretti, M. Bitelli, L. Mearini PP-03-240 Sexual health of women married to men suffering from the vascular form of sexual dysfunctions Igor Gorpinchenko, Ukraine O. Romashchenko, S. Melnikov, V. Bilogolovskaya PP-03-241 Sexual dysfunction among female patients with Behcet’s disease Pinar Kadioglu, Turkey D. Ozgil Yetkin, S. Aliustaoglu, A. S. Yalin, G. Hatemi, G. Oral, A. Kadioglu PP-03-242 The effect of pregnancy and postpartum period on female sexual function M. Resit Goren, Turkey L. Peskircioglu, N. Acar, H. Ozkardes PP-03-243 Is there an association between menopause, mood status and sexual functioning? Gabriella Gyovai, Hungary C. Huszka, A. Lakatos, F. Racz, T. Nyari, G. Ugocsai PP-03-244 Urinary incontinence in women: A questionnaire study of social and sexual quality of life Andrea Ceresoli, Italy F. Colombo, A. L. Romano, L. Rivolta, E. Austoni PP-04 Poster Presentation Ejaculatory disorders PP-04-245 Sacrolumbar intersegmental reflex circuit in men Baris Altay, Turkey C. Ertekin, F. Bademkiran, H. Uysal PP-04-246 Experience with evaluation of premature ejaculation /pe/ Ferenc Fekete, Hungary A. Rusz, I. Romics 49 50 POSTER PRESENTATIONS PP-04-247 Ejaculation latency times and their relationship with penile sensitivity in men with normal sexual function Hilde Vanden Broucke, Belgium K. Everaert, W. Peersman, H. Claes, D. Vanderschueren, M. van Kampen PP-05-254 Male to female Sex Reassignment Surgery (SRS): Comparison of two techniques Paolo Verze, Italy C. Imbimbo, A. Palmieri, N. Longo, C. Barba, D. Arcaniolo, V. Mirone PP-04-248 Relaxory neurotransmitter modulating the contractility of smooth muscle from seminalvesicle Weifu Wang, People’s Republic of China C. Wu, C. Fry, S. Minhas, D. Ralph PP-05-255 Augmentation Phalloplasty: Apical and pericavernousal penile implant Jamal Salhi, Italy M. del Prete PP-05-256 PP-04-249 Relaxory neurotransmitter modulating the contractility of smooth muscle from vas deferens Weifu Wang, People’s Republic of China C. Fry, C. Wu, S. Minhas, D. Ralph Permanent penile lengthening byintracavernous injection of n-butyl-2cyanoacrylate in dogs Fathy Moossa, Egypt K. Farag PP-05-257 Treatment of penile cripple after operations for hypospadias Wojciech Perdzynski, Poland M. Adamek PP-05-258 An audit of the presentation & management of ischaemic priapism A. Adeniyi, United Kingdom P. Anderson, P. Kumar, N. Christopher, D. Ralph, S. Minhas PP-05-259 Outcome from advanced penile cancer? A UK series O. Kayes, United Kingdom P. Anderson, P. Hegarty, D. Ralph, S. Minhas PP-05-260 Webbed and buried penis - Surgical approach Aristomenis Gekas, Greece P. Kartsaklis, I. Palaiodimos, S. Andreadakis, C. Konstantinidis, P. Stamopoulos, D. Baltogiannis, N. Sofikitis PP-05-261 A case of penile fracture with complete urethral disruption during sexual intercourse Klemen Jagodic, Slovenia M. Erklavec, I. Bizjak, S. Poteko, H. Korosec Jagodic PP-04-250 Premature ejaculation and heroin use: Is there a link? Giuseppe La Pera, Italy F. Peris, A. Carderi, Z. Marianantoni, M. S. Fattori, F. Taggi PP-04-251 Why combination treatment for premature ejaculation? Michael A. Perelman, USA PP-04-252 Premature Ejaculation: Psycho-social background of patients and treatment preferences Halim Hattat, Turkey I. Hattat, E. Akkus, B. Alici, H. Özkara PP-05 Poster Presentation Surgery, Priapism and Peyronie’s Disease PP-05-253 Our experience with Methylene Blue (methylthionine chloride MB) in the treating of priapism Giandomenico Passavanti, Italy V. Pizzuti, E. Spinosa, A. M. Aloisi, M. Carlucci, R. Paolini, A. Bragaglia POSTER PRESENTATIONS PP-05-262 Induratio penis plastica: Corporoplastic with small gauge malleable semirigid penile implant and graft of saphenous vein Mauro Silvani, Italy S. Quaranta, D. Concone, D. Minocci PP-05-263 Extracorporeal Shock Wave Therapy improves sexual performance and satisfaction in patients with Peyronie’s disease Shawket Alkhayal, United Kingdom G. John, M. Fletcher, V. Lehmann PP-05-264 Paradoxical arterial priapism: Posttraumatic monolateral low penile perfusion and curvature associated to contro-lateral arterious-cavernous laceration and fistulization. Ignazio Gattuccio, Italy E. Italiano, F. Zangara, F. Montalto, G. Savoca, S. Lo Giudice, M. Parrinello, C. Gagliardo, F. Gattuccio PP-05-265 Sex reassignment surgery for male to female transsexuals: Initial experience Rui Barbosa, Portugal N. Tomada, P. Vendeira, A. Cardoso, J. Reis, J. Amarante PP-05-266 Development of approaches to estimate the implanted three-dimensional polymeric materials for tissue engineering in genital surgery Peter Scheplev, Russia N. Garin, B. Gvasaliya, S. Gusev, G. Borisenko PP-05-267 Risk factors in development of recurrent urethral strictures after urethroplasty Peter Scheplev, Russia B. Gvasaliya, N. Garin PP-05-268 Peyronie’s disease, total penile skin necrosis and reconstruction with scrotal flap in two steps: Case report Giuseppe La Pera, Italy F. Peris, U. Anceschi, G. Maggiulli, A. Felici, M. Lentini PP-05-269 The treatment and outcomes in urethral squamous cell carcinoma Frank Soden, United Kingdom O. Kayes, A. Freeman, D. Ralph, S. Minhas PP-05-270 Fibroepithelial polyp of glans penis: A case report Roberto Sanseverino, Italy A. Baio, O. Intilla, U. Di Mauro, T. Realfonso, G. Napodano PP-05-271 Clinical characterestics of patients with Peyronie’s disease in a sexual problems andrology outpatient clinic Natarajan Kathirvel, United Kingdom K. Wylie PP-05-272 Shock-wave therapy for Peyronie’s disease: High-energy shock waves do not restore mechanism of corporal venous occlusion Igor Gorpinchenko, Ukraine PP-05-273 Concomitant placement of male sling with inflatable penile prosthesis by unique penoscrotal incision Luigi Rolle, Italy I. Morra, C. Ceruti, F. Ragni, A. Tamagnone, M. Timpano, C. Negro, D. Fontana PP-05-274 Penis (glans) carcinoma: Disassembly, glandsectomy and urethroglansplastic Omid Sedigh, Italy M. Paradiso, F. Varvello, F. Liberale, M. E. Graziano, U. Ferrando PP-05-275 Frenular Grafting ? An alternative to circumcision Amanda Spillings, United Kingdom O. Kayes, L. Chi-Yi, C. Nim, S. Minhas, D. Ralph PP-05-276 The comparison of symptoms according to the phase of Peyronie’s disease Tolga Akman, Turkey T. Oktar, O. Sanli, S. Guven, M. F. Akbulut, A. Kadioglu 51 52 POSTER PRESENTATIONS PP-05-277 Classification of disease of Peyronie Yuriy Gurzhenko, Ukraine PP-05-278 Experience of surgical treatment of patients with disease of Peyronie Igor Gorpinchenko, Ukraine E. Stahovskiy, Y. Gurzhenko, A. Kornienko PP-05-279 PP-05-280 Stage of morphological evolution of albumen shell of penis of patients with disease Peyronie Yuriy Gurzhenko, Ukraine State of hypophysial gonadal system of patients with disease of Peyronie Yuriy Gurzhenko, Ukraine L. Imshinetskaya PP-05-281 Ultrastructural characteristic of cellular elements of albumen shell of penis at disease of Peyronie Yuriy Gurzhenko, Ukraine PP-05-282 The corporoplasty with simultaneous penile prosthesis implantation in Peyronie disease Mikhail Sokolschik, Russia R. Petrovich, S. Gagarina, Y. Vasiev, I. Sadakova PP-05-283 PP-05-284 PP-05-285 PP-05-286 Painful La Peyronie disease: Are really inefficient the intracavernous injections of corticoids? Pierre Bondil, France A. Demey, F. Ozone, B. Knouzy PP-05-287 Rehabilitation after plastic penile surgery Wojciech Lauer, Poland D. Perkowski, M. Markuszewski, K. Krajka PP-05-288 Surgical treatment of Peyronie disease Kazimierz Krajka, Poland M. Matuszewski, W. Moszczynski PP-05-289 Systemic vascular abnormalities in Peyronie’s disease Vineet Agrawal, United Kingdom S. Minhas, E. Ellins, A. Donald, J. Halcox, D. Ralph PP-06 Poster Presentation General Issues in Sexual Medicine PP-06-290 Determination of Turkish patient satisfaction after penile prosthesis surgery M. Resit Goren, Turkey B. Cakar, L. Peskircioglu, H. Ozkardes The real-life safety and efficacy of vardenafil: An international postmarketing surveillance study results from 5373 Polish patients Piotr Trypens, Poland A. Depko, R. Dadej, H. Landen PP-06-291 Idiopathic Priapism in patient with Cerebellar Ataxia and left colon neoplasm: A case report Massimo Polito, Italy W. Giannubilo, M. Leone, G. d’Anzeo, M. Dellabella, G. Muzzonigro Evaluation of a Sexual Assessment Monitor (SAM); a diagnostic device for premature ejaculation W. Dinsmore, Ireland D. Ralph, P. Kell, K. Wylie, J. Dean, C. Novak, J. Wyllie, M. Wyllie PP-06-292 Half of those reporting a sexual problem are satisfied with their sexual function: Results from the Hoppes study Paraskevi-Sofia Kirana, Greece M. Fridakis, E. Nakopoulou, R. Rosen, J. McKinlay, D. Hatzichristou Our experience of the evolution of priapism Pierre Bondil, France K. Bouraoui, F. Ozone, A. Demey, F. Adawi POSTER PRESENTATIONS PP-06-293 Patients’ self-perception of sexual function: Results from the HOPPES study Paraskevi-Sofia Kirana, Greece M. Fridakis, G. Salpiggidis, R. Rosen, J. McKinlay, D. Hatzichristou PP-06-294 Perceptions about sexual health issues in nursing Evangelia Nakopoulou, Greece S. Papaharitou, M. Moraitou, F. Ferenidou, L. Athanasiadis PP-06-295 Presence of sexual problems may not indicate dissatisfaction from sexual life: Results from the HOPPES study Paraskevi-Sofia Kirana, Greece M. Fridakis, S. Papacharitou, R. Rosen, J. Mckinlay, D. Hatzichristou PP-06-296 Treatment seeking behavior for sexual problems: Results from the HOPPES study Paraskevi-Sofia Kirana, Greece M. Fridakis, K. Hatzimouratidis, R. Rosen, J. Mckinlay, D. Hatzichristou PP-06-297 Prevalence and diversity of sexual disorders among male and female patients referred to family healthcare clinic,Tehran- Iran Mansour Ghavam, Iran PP-06-298 Is there a significance of histamine in the control of penile erection? Armin J. Becker, Germany S. Ückert, M. Schröder, F. Scheller, U. Jonas, C. G. Stief PP-06-300 A history of sexual abuse: How reliable is a self-administered questionnaire compared to an administered questionnaire? Henk Willem Elzevier, The Netherlands P. J. Voorham van der Zalm, R. C. M. Pelger PP-06-301 The use of sexual symbolism and metaphor in the psychosexual treatment of male anorgasmia - a case report Susan Pacey, United Kingdom PP-06-302 “san-sex.ro” - esda Romanian connection Nicolae Calomfirescu, Romania A. Liiceanu, C. Belinski, D. Gaita, S. Fiica, C. Calomfirescu, V. Arama, A. Manu, V. Voinescu, V. Orsavski, SanSex Expert Group PP-06-303 Sexual information level in active women population in Romania Nicolae Calomfirescu, Romania S. Fiica, C. Belinski, D. Gaita, D. L. Bucuras, A. Cambosie, M. Mota, A. Bulai, AMSR Study Group PP-06-304 Remembered international index of erectile function domain scores are not accurate in assessing preoperative sexual function (sf) in candidates to bilateral nerve sparing radical prostatectomy (bnsrp) Andrea Salonia, Italy A. Gallina, G. Zanni, A. Briganti, A. Sacca, F. Deho, U. Capitanio, F. Pellucchi, F. Sozzi, P. Rigatti, F. Montorsi PP-06-305 Potential impact of the educational level impact on the rate of treatment adherence in patients with erectile dysfunction (ed). Results of a single major tertiary acadamic centre Andrea Salonia, Italy F. Abdullah, F. Pellucchi, R. Molina, A. Briganti, G. Zanni, F. Deho, G. Petralia, L. Barbieri, P. Rigatti, F. Montorsi PP-06-306 Unsuccessful investigation of preoperative couple’s and sexual relationship issues in candidates to radical prostatectomy Andrea Salonia, Italy G. Zanni, U. Capitanio, A. Gallina, A. Briganti, F. Deho, E. Strada, N. Suardi, P. Rigatti, F. Montorsi 53 54 POSTER PRESENTATIONS PP-06-308 A new model for a supraregional penile cancer service utilising an urgent fax response system and regular teleconferenced multidisciplinary (MDT) meetings Duncan Summerton, United Kingdom N. Mayer, M. Bamford, A. Rajesh, K. Mulcahy, T. Terry PP-06-309 Pregnancy in adolescence Isabel Guimaraes, Portugal I. Almeida PP-06-310 Autoerotic accidents in legal medicine - a retrospective study of 17 cases Knut Albrecht, Germany F. Mansouri, D. Schultheiss, S. Ueckert, U. Jonas, D. Breitmeier PP-06-311 Our experience of male dyspareunia Pierre Bondil, France F. Ozone, K. Bouraoui, A. Demey, F. Adawi PP-06-312 Analysis of data related to the Siena’s experience during the Prevention Week in Andrology, 2006 Roberto Ponchietti, Italy V. Tallis, S. Trovarelli, E. Paliouri, F. Trovarelli PP-06-313 Characterization of the BDSM community in Portugal: An internet based study Patricia Pascoal, Portugal R. Rui Henriques, N. Monteiro Pereira PP-06-314 Body image and sexuality: Comparative study Ana Filipa Beato, Portugal P. Pascoal, I. Narciso Davide, N. Monteiro Pereira PP-06-315 Desire to improve sexual experiences and willingness to seek treatment for erectile dysfunction: Results of the Global Better Sex Survey Michael Kirby, United Kingdom S. Glina, Y. Vardi, K. Hvidsten LIST OF EXHIBITORS Exhibitors Booth No. Booth No. Exhibitors American Medical Systems Europe B.V. Ardana Bioscience Ltd. Bayer HealthCare AG Blackwell Publishing Coloplast (former Mentor Porges) EAU ESDA ESSM 10th ESSM Congress Lisbon ISSM Ipsen Pharma Lilly ICOS LLC Nature Publishing Pfizer Inc. Plethora Solutions/Timm Medical Technologies Procter & Gamble Pharmaceuticals Schering AG Solvay Pharmaceuticals GmbH Uroan 21 6 1 8 14 3 15 16 18 19 17 11 7 2 10 1 2 3 4 5 Ardana Bioscience Ltd. Nature Publishing Coloplast (former Mentor Porges) Uroan 21 Plethora Solutions/Timm Medical Technologies American Medical Systems Europe B.V. Lilly ICOS LLC Bayer HealthCare AG Procter & Gamble Pharmaceuticals Pfizer Inc. Ipsen Pharma Solvay Pharmaceuticals GmbH Schering AG Blackwell Publishing EAU ESDA ISSM ESSM 10th ESSM Congress Lisbon 6 7 8 9 10 11 12 13 14 15 16 17 18 19 5 9 13 12 4 Exhibition Plan - First Floor 18 1 2 17 3 19 8 7 6 15 16 4 5 9 10 Zeremoniensaal 11 12 Festsaal 13 14 55 56 LIST OF CHAIRPERSONS AND PRESENTERS Name Page A Name Page Bhatia, V. 30, 42 Abdo, C. 28 Bitelli, M. 46 Adeniyi, A. 50 Bitzer, J. 37 Agrawal, V. 36, 52 Boer, B.-J. de 36 Ahn, G. J. Akkus, E. 43 Bondil, P. 52, 54 29, 37 Booth, C. 33 Akman, T. 51 Boul, L. 28 Albersen, M. 38 Briganti, A. Albrecht, K. 54 Brock, G. Alder, J. 32 Brodak, M. Alkhayal, S. Allers, K. 43, 51 Buvat, J. 33, 38 26, 34, 35 43 23, 25, 29 28 Altay, B. 26, 49 Anderson, P. 35, 36 Andreadakis, S. 46 Angulo Frutos, J. 28 Arver, S. 30, 36 Aslan, E. 49 Atan, A. 30, 41 Athanasiadis, L. 28 Aughton, K. 26 Austoni, E. 23, 39 Aversa, A. 29, 34 B C Cabral Ribeiro, J. 35 Cakan, M. 46 Calomfirescu, N. 46, 53 Carrier, S. 28, 44 Casey, R. 24 Cayan, S. 35 Ceresoli, A. 49 Chen, J. Chevret Measson, M. 36, 37, 38 33 Chitale, S. 28, 47 Cho, H.H. 49 Cimen, S. 43 Banks, I. 47 Bannowsky, A. 38 Claes, H. Barbosa, R. 51 Clement, P. 36 Coca, V. 49 30 40, 43, 46 Barnes, T. 30, 33 Basar, M. 29 Collins, S. Beardsworth, A. 43 Colombo, F. Becker, A. J. 53 Corona, G. 25, 28, 32, 46 Behre, H. 23 Corretti, G. 43 33, 34 Costa, P. 34 27, 30, 47 Cuzin, B. 29 Behr-Roussel, D. Bettocchi, C. 23, 36, 38, 40, 47 LIST OF CHAIRPERSONS AND PRESENTERS Name Page D Dachille, G. 47 Damsted Petersen, C. 31 Danes, B. 28 Name Page Fugl-Meyer, K. 39 Fusco, F. 36 G Galzerano, M. 38 40 Gamidov, S. 40 Delibas, M. 41 Garaffa, G. Demir, O. 45 Gattuccio, I. Demirezen, E. 49 Gekas, A. Dean, J. 23, 28, 37 Deho, F. 35, 39, 40 51 46, 50 Depko, A. 29, 44 Ghavam, M. Dinsmore, W. 36, 52 Giraldi, A. 30, 31, 36 24, 39, 41 Djavan, B. 38 Giuliano, F. Dogru, T. 32 Goldmeier, D. Droupy, S. 39 Goldstein, I. 44 Golombok, S. Dugre, H. Gorpinchenko, I. E Greenspan, M. Eardley, I. 23, 25, 36, 42 Gruenwald, I. Ebert, A. 35 Guimaraes, I. 53 25 23, 26, 32, 40 26 49, 51, 52 46 39, 42 54 Edwards, D. 30, 47 Gurzhenko, Y. Elzevier, H. W. 31, 53 Gutierrez, P. R. 33 Gyovai, G. 49 Enzlin, P. 39 Esen, A. 48 35, 52 H F Hackett, G. 28, 29, 34 Fekete, F. 49 Hallam, R. 28 Felblinger, D. 26 Haro, J.M. 34 Ferenidou, F. 27 Hattat, H. 50 Fernandez Lozano, A. 25 Hatzichristou, D. 25, 34 54 Hatzimouratidis, K. 29, 38 Filipa Beato, A. Filippi, S. 25, 46 Hawcock, T. 27 Fisher, W. 29 Hedlund, H. 33 Franco, G. 36 Hedlund, P. 31 Fugl-Meyer, A. 27, 30 Hekal, E. 41, 45 57 58 LIST OF CHAIRPERSONS AND PRESENTERS Name Hellstrom, W. Page 31, 35, 43 Name Page Kimoto, Y. 43 40 Her, M. 26 King, R. Heufelder, A. 23 Kirana, P.-S. Hobbs, K. 32 Kirby, M. Hodges, L. 48 Kocsis, A. 39 Hotston, M. 45 Konstantinopoulos, A. 43 Huk J. 43 Korda, J. B. Huri, E. 49 Koskimaki, J. 42 Hurn, W. 45 Krajka, K. 52 Kristensen, E. 25 Kunelius, P. 38 I Iacona, F. Ioakimidis, N. 33, 52, 53 27, 54 26, 40 48 45, 48 J L La Pera, G. 46, 50, 51 Lackner, J. 33 Jackson, G. 23 Lau, D. 44 Jagodic, K. 50 Lauer, W. 52 39 Jannini, E. 28, 30 Lemaire, A. Joniau, S. 38, 46 Lemos, M. 39 Jordan, G. 39 Letizia, P. 23 Juenemann, K.-P. 27 Li, C. 40 Jungwirth, A. 28 Lobik, L. 45 Justo, D. 45 Longhi, E. Luchitskiy, V. 25, 47 47 K Kadioglu, A. 23, 29, 34 M Kadioglu, P. 46, 49 Maggi, M. 27 Kamenov, Z. 28, 46 Mancini, M. 30 Kan, I. 47 Martin-Morales, A. Karakitsios, K. 45 Martinez-Salamanca, J. I. 24, 31 Kathirvel, N. 51 Mazo, E. Kayes, O. 50 McMahon, C. 24 Kettas, E. 48 Meryn, S. 29 Kim, H.-Y. 48 Minhas, S. 35 28 33, 40 LIST OF CHAIRPERSONS AND PRESENTERS Name Mirone, V. Modi, N. Moncada, I. Monteiro Pereira, N. Montorsi, F. Page 31, 34 30 23, 28, 40 Name Porav-Hodade, D. Porst, H. Pryor, J. Page 41 35, 37 27 40 23, 25, 31 R Moossa, F. 50 Ralph, D. 23, 27 Morelli, A. 34 Resit Goren, M. 49, 52 Mulhall, J. 27, 31 Murat, N. 32 N Richards, N. 26 Richardson, D. 26 Riley, A. 34 Rokkas, K. 28, 32, 48 Nachtigall, L. 26 Rolle, L. 51 Nakopoulou, E. 53 Romanyuk, M. 46 Nicol, S. 28 Rosen, R. 35, 44 Nim, C. 35 Rossello Barbara, M. 27 Nowosielski, K. 48 Roumeguere, T. 43 Rub, R. 36 P Rubio-Aurioles, E. Pacey, s. 53 Palha, P. 39 Papacharitou, S. 25, 39 Papadoukakis, S. Paradiso, P. 27, 29, 30, 44 S Saad, F. 47 38 Saenz de Tejada, I. 27 35 Salhi, J. 50 Pascoal, P. 26, 54 Salonia, A. Passavanti, G. 45, 50 Sand, M. 31, 36, 38, 41, 53 26, 32, 48 Pechersky, A. 45 Sanseverino, R. Perdzynski, W. 50 Scheplev, P. 39, 51 Schulman, C. 28, 31 Perelman, M. A. Perovic, S. 31, 50 23, 35, 39 51 Schultheiss, D. 34 Schwenkhagen, A. 37 Pescatori, E. S. 38 Peskircioglu, L. 26, 27 Sedigh, O. 35, 40, 51 Plas, E. 23, 34 Shabsigh, R. 25, 36, 40 Polito, M. 47, 52 Silvani, M. 51 Simonelli, C. 33 Ponchietti, R. 54 59 60 LIST OF CHAIRPERSONS AND PRESENTERS Name Page Soden, F. 51 Sohn, M. 23, 37 Sokolschik, M. 35, 52 Sönksen, J. 34, 36 Sorrentino, R. 39 Spera, E. 46 Spillings, A. 27, 51 Stackl, W. 38 Stanislavov, R. 44 Stecher, V. 33 Stief, C. 27, 29, 35 Stien, R. 34 Studd, J. 32 Summerton, D. 54 Sungur, M. 33 Symonds, T. 37 T Talseth, T. 38 Tinel, H. 49 Topic, B. 26 Trypens, P. 52 U Ucar, G. Ückert, S. Usta, M. F. 48 33, 37, 39 29, 45 Name Page V Vanden Broucke, H. Vardi, Y. Vendeira, P. Verheyden, B. Verze, P. Vignozzi, L. Vinarov, A. Vlachiotis, J. Vlachopoulos, C. 23, 25, 38, 25, 42, 28, 32, 33, 50 31 47 44 50 38 44 45 48 W Waldinger, M. D. Waldkirch, E. Wang, W. Wayman, C. Wespes, E. Wilson, L. Wingen, G. van Wylie, K. Wyllie, M. 30 ,33 32, 47 50 44 34 32 32 28 37 Y Yaman, O. Yassin, A. Yildirim, G. 33 40, 47 49 Z Zucchi, A. Zumbe, J. 49 44
© Copyright 2024 Paperzz
